Advertisement

Bacterial Infections

  • Washington C. WinnJr.
  • P. Rocco LaSala
  • Kevin O. Leslie

Abstract

In Osier’s time, bacterial pneumonia was a dreaded event, so important that he borrowed John Bunyan’s characterization of tuberculosis and anointed the pneumococcus, as the prime pathogen, “Captain of the men of death.”1 One hundred years later much has changed, but much remains the same. Pneumonia is now the sixth most common cause of death and the most common lethal infection in the United States. Hospital-acquired pneumonia is now the second most common nosocomial infection.2 It was documented as a complication in 0.6% of patients in a national surveillance study,3 and has been reported in as many as 20% of patients in critical care units.4 Furthermore, it is the leading cause of death among nosocomial infections.5 Leu and colleagues6 were able to associate one third of the mortality in patients with nosocomial pneumonia to the infection itself. The increase in hospital stay, which averaged 7 days, was statistically significant. It has been estimated that nosocomial pneumonia produces costs in excess of $500 million each year in the United States, largely related to the increased length of hospital stay.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Osler W. Practice of medicine. 5 ed. New York: Appleton, 1904.Google Scholar
  2. 2.
    Scheld WM, Mandell GL. Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy. Rev Infect Dis 1991;13:S743–S751.PubMedCrossRefGoogle Scholar
  3. 3.
    Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance 1984. MMWR CDC Surveill Summ 1986;35:17SS–29SS.PubMedGoogle Scholar
  4. 4.
    Pugliese G, Lichtenberg DA. Nosocomial bacterial pneumonia: an overview. Am J Infect Control 1987;15:249–265.PubMedCrossRefGoogle Scholar
  5. 5.
    Gross PA, Neu HC, Aswapokee P, van Antwerpen C, Aswapokee N. Deaths from nosocomial infections: experience in a university hospital and a community hospital. Am J Med 1980;68:219–223.PubMedCrossRefGoogle Scholar
  6. 6.
    Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 1989;129:1258–1267.PubMedGoogle Scholar
  7. 7.
    McGowan JE Jr. Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Rev Infect Dis 1985;73:S357–S370.CrossRefGoogle Scholar
  8. 8.
    Dunglison R. Medical lexicon. A dictionary of medical science. 1 ed. Philadelphia: Henry C. Lea, 1874.Google Scholar
  9. 9.
    Welsh DA, Mason CM. Host defense in respiratory infections. Med Clin North Am 2001;85(6):1329–1347.PubMedCrossRefGoogle Scholar
  10. 10.
    Green GM, Jakab GJ, Low RB, Davis GS. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 1977;115:479–514.PubMedGoogle Scholar
  11. 11.
    Dondero TJ Jr, Rendtorff RC, Mallison GF, et al. An outbreak of Legionnaires’ disease associated with a contaminated air-conditioning cooling tower. N Engl J Med 1980;302:365–370.PubMedCrossRefGoogle Scholar
  12. 12.
    Helms CM, Massanari RM, Zeitler R, et al. Legionnaires’ disease associated with a hospital water system: a cluster of 24 nosocomial cases. Ann Intern Med 1983;99:172–178.PubMedCrossRefGoogle Scholar
  13. 13.
    Klaucke DN, Vogt RL, LaRue D, et al. Legionnaires’ disease: the epidemiology of two outbreaks in Burlington, Vermont, 1980. Am J Epidemiol 1984;119:382–391.PubMedGoogle Scholar
  14. 14.
    Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453–1460.PubMedCrossRefGoogle Scholar
  15. 15.
    Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988;108:653–657.PubMedCrossRefGoogle Scholar
  16. 16.
    CDC. Anthrax contamination of Haitian goatskin products. MMWR Morb Mortal Wkly Rep 1977;26:31.Google Scholar
  17. 17.
    CDC. Human anthrax—Colorado. MMWR Morb Mortal Wkly Rep 1980;29(39):469–470.Google Scholar
  18. 18.
    Centers for Disease Control. Update: Cutaneous anthrax in a laboratory worker—Texas, 2002. MMWR Morb Mortal Wkly Rep 2002;51(22):482.Google Scholar
  19. 19.
    Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999;341(11):815–826.PubMedCrossRefGoogle Scholar
  20. 20.
    Albrink WS, Brooks SM, Biron RE, Kopel M. Human inhalation anthrax. A report of three fatal cases. Am J Pathol 1960;36:457–471.PubMedGoogle Scholar
  21. 21.
    Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266(5188):1202–1208.PubMedCrossRefGoogle Scholar
  22. 22.
    Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002;8(10):1019–1028.PubMedCrossRefGoogle Scholar
  23. 23.
    Muder RR, Yu VL, Woo AH. Mode of transmission of Legionella pneumophila. A critical review. Arch Intern Med 1986;146:1607–1612.PubMedCrossRefGoogle Scholar
  24. 24.
    Girod JC, Reichman RC, Winn WC Jr, Klaucke DN, Vogt RL, Dolin R. Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila. Arch Intern Med 1982;142:545–547.PubMedCrossRefGoogle Scholar
  25. 25.
    Joly JR, Winn WC. Correlation of subtypes of Legionella pneumophila defined by monoclonal antibodies with epidemiological classification of cases and environmental sources. J Infect Dis 1984;150:667–671.PubMedCrossRefGoogle Scholar
  26. 26.
    Arnow PM, Chou T, Weil D, Shapiro EN, Kretzschmar C. Nosocomial Legionnaires’ disease caused by aerosolized tap water from respiratory devices. J Infect Dis 1982;146:460–467.PubMedCrossRefGoogle Scholar
  27. 27.
    Lowry PW, Blankenship RJ, Gridley W, Troup NJ, Tompkins LS. A cluster of Legionella sternal-wound infections due to postoperative topical exposure to contaminated tap water. N Engl J Med 1991;324:109–113.PubMedCrossRefGoogle Scholar
  28. 28.
    Huxley EJ, Viroslav J, Gray WR, et al. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978;64:564–568.PubMedCrossRefGoogle Scholar
  29. 29.
    Mackowiak PA. The normal microbial flora. N Engl J Med 1982;307(2):83–93.PubMedCrossRefGoogle Scholar
  30. 30.
    Foy HM, Wentworth B, Kenny GE, Kloeck JM, Grayston JT. Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. Am Rev Respir Dis 1975;111:595–603.PubMedGoogle Scholar
  31. 31.
    Winther FO, Horthe K, Lystad A, Vellar OD. Pathogenic bacterial flora in the upper respiratory tract of healthy students. Prevalence and relationship to nasopharyngeal inflammatory symptoms. J Laryngol Otol 1974;88(5):407–412.PubMedCrossRefGoogle Scholar
  32. 32.
    Johanson WG Jr, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969;281:1137–1140.PubMedCrossRefGoogle Scholar
  33. 33.
    Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 1972;77:701–706.PubMedCrossRefGoogle Scholar
  34. 34.
    Fainstein V, Musher D. Bacterial adherence to pharyngeal cells in smokers, nonsmokers, and chronic bronchitics. Infect Immun 1979;26,1:178–182.PubMedGoogle Scholar
  35. 35.
    Bartlett JG, O’Keefe P, Tally FP, Louie TJ, Gorbach SL. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986;146:868–871.PubMedCrossRefGoogle Scholar
  36. 36.
    Lorber B, Swenson RM. Bacteriology of aspiration pneumonia. A prospective study of community-and hospital-acquired cases. Ann Intern Med 1974;81:329–331.PubMedCrossRefGoogle Scholar
  37. 37.
    Winn WC Jr, Allen SD, Janda WM, et al. Koneman’s color atlas and textbook of diagnostic microbiology. 6 ed. Philadelphia: JB Lippincott, 2006.Google Scholar
  38. 38.
    Johanson WG Jr, Woods DE, Chaudhuri T. Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J Infect Dis 1979;139:667–673.PubMedCrossRefGoogle Scholar
  39. 39.
    Johanson WG Jr, Higuchi JH, Chaudhuri TR, Woods DE. Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis 1980;121:55–63.PubMedGoogle Scholar
  40. 40.
    Todd TR, Franklin A, Mankinen-Irvin P, Gurman G, Irvin RT. Augmented bacterial adherence to tracheal epithelial cells is associated with gram-negative pneumonia in an intensive care unit population. Am Rev Respir Dis 1989;140:1585–1589.PubMedCrossRefGoogle Scholar
  41. 41.
    Mims CA, Nash A, Stephen J. Mims’ Pathogenesis of infectious disease. 5 ed. Burlington, MA: Elsevier Science and Technology, 2001.Google Scholar
  42. 42.
    Conway B, Ronald A. An overview of some mechanisms of bacterial pathogenesis. Can J Microbiol 1988;34:281–286.PubMedCrossRefGoogle Scholar
  43. 43.
    Wilson R, Dowling RB, Jackson AD. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J 1996;9(7):1523–1530.PubMedCrossRefGoogle Scholar
  44. 44.
    Woods DE, Strauss DC, Johanson WG Jr, Bass JA. Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. J Infect Dis 1981;143:784–790.PubMedCrossRefGoogle Scholar
  45. 45.
    Woods DE, Strauss DC, Johanson WG Jr, Bass JA. Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest 1981;68:1435–1440.PubMedCrossRefGoogle Scholar
  46. 46.
    Baskerville A, Fitzgeorge RB, Broster M, Hambleton P, Dennis PJ. Experimental transmission of legionnaires’ disease by exposure to aerosols of Legionella pneumophila. Lancet 1981;2:1389–1390.PubMedCrossRefGoogle Scholar
  47. 47.
    Davis GS, Winn WC Jr, Gump DW, Craighead JE, Beaty HN. Legionnaires’ pneumonia after aerosol exposure in guinea pigs and rats. Am Rev Respir Dis 1982;126:1050–1057.PubMedGoogle Scholar
  48. 48.
    Winn WC Jr, Davis GS, Gump DW, Craighead JE, Beaty HN. Legionnaires’ pneumonia after intratracheal inoculation of guinea pigs and rats. Lab Invest 1982;47:568–578.PubMedGoogle Scholar
  49. 49.
    Green GM. Alveolobronchiolar transport mechanisms. Arch Intern Med 1973;131:109–114.PubMedCrossRefGoogle Scholar
  50. 50.
    Sorokin SP, Brain JD. Pathways of clearance in mouse lungs exposed to iron oxide aerosols. Anat Rec 1975;181:581–626.PubMedCrossRefGoogle Scholar
  51. 51.
    Green GM, Kass EH. The role of the alveolar macrophage in the clearance of bacteria from the lung. J Exp Med 1964;119:167–175.PubMedCrossRefGoogle Scholar
  52. 52.
    Johanson WG Jr, Kennedy MG, Bonte FJ. Use of technetium (99mTc) as a bacterial label in lung clearance studies. Appl Microbiol 1973;25:592–594.PubMedGoogle Scholar
  53. 53.
    Creasia DA, Nettesheim P, Hammons AS. Impairment of deep lung clearance by influenza virus infection. Arch Environ Health 1973;26:197–201.PubMedCrossRefGoogle Scholar
  54. 54.
    Carson JL, Collier AM, Hu SS. Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. N Engl J Med 1985;312:463–468.PubMedCrossRefGoogle Scholar
  55. 55.
    Ruppert D, Jakab GJ, Sylwester DL, Green GM. Sources of variance in the measurement of intrapulmonary killing of bacteria. J Lab Clin Med 1976;87:544–558.PubMedGoogle Scholar
  56. 56.
    Berendt RF. Survival of Legionella pneumophila in aerosols: effect of relative humidity. J Infect Dis 1980;141:689.PubMedCrossRefGoogle Scholar
  57. 57.
    Hambleton P, Broster MG, Dennis PJ, Henstridge R, Fitzgeorge R, Conlan JW. Survival of virulent Legionella pneumophila in aerosols. J Hyg (Lond) 1983;90:451–460.PubMedCrossRefGoogle Scholar
  58. 58.
    Johnston RB, Jr. The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis of tissue damage. Rev Infect Dis 1981;3:282–288.PubMedCrossRefGoogle Scholar
  59. 59.
    Winkelstein JA, Tomasz A. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol 1978;120:174–178.PubMedGoogle Scholar
  60. 60.
    Kadioglu A, Andrew PW. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 2004;25(3):143–149.PubMedCrossRefGoogle Scholar
  61. 61.
    Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 2004;172(6):3377–3381.PubMedGoogle Scholar
  62. 62.
    Coonrod JD, Rehm SR, Yoneda MD. Pneumococcal killing in the alveolus. Evidence for a non-phagocytic mechanism for early clearance. Chest 1983;83:S89.Google Scholar
  63. 63.
    Winkelstein JA. The role of complement in the host’s defense against Streptococcus pneumoniae. Rev Infect Dis 1981;3:289–298.PubMedCrossRefGoogle Scholar
  64. 64.
    Gross GN, Rehm SR, Pierce AK. The effect of complement depletion on lung clearance of bacteria. J Clin Invest 1978;373–378.Google Scholar
  65. 65.
    Heidbrink PJ, Toews GB, Gross GN, Pierce AK. Mechanisms of complement-mediated clearance of bacteria from the murine lung. Am Rev Respir Dis 1982;125:517–520.PubMedGoogle Scholar
  66. 66.
    LaForce FM, Kelley WJ, Huber GL. Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material. Am Rev Respir Dis 1977;108:784–790.Google Scholar
  67. 67.
    Jonsson S, Musher DM, Goree A, Lawrence EC. Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis 1986;133:136–140.PubMedGoogle Scholar
  68. 68.
    Kuroki Y, Sano H. Functional roles and structural analysis of lung collectins SP-A and SP-D. Biol Neonate 1999;76Suppl 1:19–21.PubMedCrossRefGoogle Scholar
  69. 69.
    Delclaux C, Azoulay E. Inflammatory response to infectious pulmonary injury. Eur Respir J Suppl 2003;42:10s–14s.PubMedCrossRefGoogle Scholar
  70. 70.
    Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000;173:39–51.PubMedCrossRefGoogle Scholar
  71. 71.
    Simon RH, Paine R, III. Participation of pulmonary alveolar epithelial cells in lung inflammation. J Lab Clin Med 1995;126(2):108–118.PubMedGoogle Scholar
  72. 72.
    O’Brien AD, Standiford TJ, Bucknell KA, Wilcoxen SE, Paine R, III. Role of alveolar epithelial cell intercellular adhesion molecule-1 in host defense against Klebsiella pneumoniae. Am J Physiol 1999;276(6 pt 1):L961–L970.PubMedGoogle Scholar
  73. 73.
    Wood WB. Studies on the mechanism of recovery in pneumococcal pneumonia. I. The action of type specific antibody upon the pulmonary lesion in experimental pneumonia. J Exp Med 1941;73:201–222.PubMedCrossRefGoogle Scholar
  74. 74.
    Davis GS, Winn WC Jr, Gump DW, Beaty HN. The kinetics of early inflammatory events during experimental pneumonia due to Legionella pneumophila in guinea pigs. J Infect Dis 1983;148:823–835.PubMedCrossRefGoogle Scholar
  75. 75.
    Horwitz MA, Silverstein SC. Interaction of the legionnaires’ disease bacterium (Legionella pneumophila. with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication. J Exp Med 1981;153:398–406.PubMedCrossRefGoogle Scholar
  76. 76.
    Kunkel SL, Strieter RM. Cytokine networking in lung inflammation. Hosp Pract 1990;25:63–69.Google Scholar
  77. 77.
    Onofrio JM, Toews GB, Lipscomb MF, Pierce AK. Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus. Am Rev Respir Dis 1983;127:335–341.PubMedGoogle Scholar
  78. 78.
    Pine JH, Richter WR, Esterly JR. Experimental lung injury. I. Bacterial pneumonia: ultrastructural, autoradiographic and histochemical observations. Am J Pathol 1973;73:115–130.PubMedGoogle Scholar
  79. 79.
    Pierce AK, Reynolds RC, Harris GD. Leukocytic response to inhaled bacteria. Am Rev Respir Dis 1977;116:679–684.PubMedGoogle Scholar
  80. 80.
    Vial WC, Toews GB, Pierce AK. Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae. Am Rev Respir Dis 1984;129:87–91.PubMedGoogle Scholar
  81. 81.
    Shaw JO, Henson PM, Henson JE, et al. Lung inflammation induced by complement-derived chemotactic fragments in the alveolus. Lab Invest 1980;42:547–558.PubMedGoogle Scholar
  82. 82.
    Larsen GL, McCarthy K, Webster RO, Henson J, Henson PM. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation. Am J Pathol 1980;100:179–192.PubMedGoogle Scholar
  83. 83.
    Coonrod JD, Rylko-Bauer B. Complement levels in pneumococcal pneumonia. Infect Immun 1977;18:14–22.PubMedGoogle Scholar
  84. 84.
    Gadek JE, Hunninghake GW, Zimmerman RL, Crystal RG. Regulation of the release of alveolar macrophagederived neutrophil chemotactic factor. Am Rev Respir Dis 1980;121:723–733.PubMedGoogle Scholar
  85. 85.
    Nelson S, Mason CM, Kolls J, Summer WR. Pathophysiology of pneumonia. Clin Chest Med 1995;16(1):1–12.PubMedGoogle Scholar
  86. 86.
    Loosli CG, Baker RF. Acute experimental pneumococcal (type 1) pneumonia in the mouse: the migration of leukocytes from the pulmonary capillaries into the alveolar spaces as revealed by the electron microscope. Trans Am Clin Climatol Assoc 1962;74:15–28.PubMedGoogle Scholar
  87. 87.
    Morganroth ML, Till GO, Kunkel RG, Ward PA. Complement and neutrophil-mediated injury of perfused rat lungs. Lab Invest 1986;54:507–514.PubMedGoogle Scholar
  88. 88.
    Till GO, Morganroth ML, Kunkel R, Ward PA. Activation of C5 by cobra venom factor is required in neutrophilmediated lung injury in the rat. Am J Pathol 1987;129:44–53.PubMedGoogle Scholar
  89. 89.
    Hulbert WC, Walker DC, Hogg JC. The site of leukocyte migration through the tracheal mucosa in the guinea pig. Am Rev Respir Dis 1981;124:310–316.PubMedGoogle Scholar
  90. 90.
    Velo GP, Spector WG. The origin and turnover of alveolar macrophages in experimental pneumonia. J Pathol 1973;109:7–19.PubMedCrossRefGoogle Scholar
  91. 91.
    Dal Nogare AR, Toews GB. Characteristics of alveolar macrophages in an animal model of resolving pulmonary inflammation. Am Rev Respir Dis 1990;142:660–667.CrossRefGoogle Scholar
  92. 92.
    Doherty DE, Downey GP, Worthen G, Haslett C, Henson PM. Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils. Lab Invest 1988;59(2):200–213.PubMedGoogle Scholar
  93. 93.
    Shennib H, Nguyen D, Guttmann RD, Mulder DS. Phenotypic expression of bronchoalveolar lavage cells in lung rejection and infection. Ann Thorac Surg 1991;51:630–635.PubMedCrossRefGoogle Scholar
  94. 94.
    Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage—the role of oxygen, shock, and related factors. A review. Am J Pathol 1976;85(1):209–228.PubMedGoogle Scholar
  95. 95.
    Pache JC, Christakos PG, Gannon DE, Mitchell JJ, Low RB, Leslie KO. Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol 1998;11(11):1064–1070.PubMedGoogle Scholar
  96. 96.
    Lakshminarayan S, Stanford RE, Petty TL. Prognosis after recovery from adult respiratory distress syndrome. Am Rev Respir Dis 1976;113(1):7–16.PubMedGoogle Scholar
  97. 97.
    Breiman RF, Horwitz MA. Guinea pigs sublethally infected with aerosolized Legionella pneumophila deve-lop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracel-lular pathogens. J Exp Med 1987;165:799–811.PubMedCrossRefGoogle Scholar
  98. 98.
    Blander SJ, Horwitz MA. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires’ disease. J Exp Med 1989;169:691–705.PubMedCrossRefGoogle Scholar
  99. 99.
    Nash TW, Libby DM, Horwitz MA. Interaction between the legionnaires’ disease bacterium (Legionella pneumophila. and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest 1984;74:771–782.PubMedCrossRefGoogle Scholar
  100. 100.
    Nash TW, Libby DM, Horwitz MA. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol 1988;140:3978–3981.PubMedGoogle Scholar
  101. 101.
    Black SB, Shinefield HR. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatr Infect Dis J 1992;11:610–613.PubMedGoogle Scholar
  102. 102.
    Musher DM, Johnson B Jr, Watson DA. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun 1990;58:3871–3876.PubMedGoogle Scholar
  103. 103.
    Snapper CM, Shen Y, Khan AQ, et al. Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol 2001;22(6):308–311.PubMedCrossRefGoogle Scholar
  104. 104.
    Lee CJ, Lee LH, Frasch CE. Protective immunity of pneumococcal glycoconjugates. Crit Rev Microbiol 2003;29(4):333–349.PubMedCrossRefGoogle Scholar
  105. 105.
    Zysk G, Bethe G, Nau R, et al. Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease. J Infect Dis 2003;187(2):330–333.PubMedCrossRefGoogle Scholar
  106. 106.
    Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003;197(7):939–945.PubMedCrossRefGoogle Scholar
  107. 107.
    Dunn MM, Toews GB, Hart D, Pierce AK. The effects of systemic immunization on pulmonary clearance of Pseudomonas aeruginosa. Am Rev Respir Dis 1985;131:426–431.PubMedGoogle Scholar
  108. 108.
    LaForce FM, Boose DS, Mills DM. Heightened lung bactericidal activity in mice after aerosol immunization with Re 595 Salmonella minnesota: importance of cellular rather than humoral factors. J Infect Dis 1980;142:421–431.PubMedCrossRefGoogle Scholar
  109. 109.
    Harrow EM, Jakab GJ, Brody AR, Green GM. The pulmonary response to a bacteremic challenge. Am Rev Respir Dis 1975;112:7–16.PubMedGoogle Scholar
  110. 110.
    Mayer KH, Zinner SH. Bacterial pathogens of increasing significance in hospital-acquired infections. Rev Infect Dis 1985;73:S371–S379.CrossRefGoogle Scholar
  111. 111.
    Winn WC Jr. Legionnaires disease: historical perspective. Clin Microbiol Rev 1988;1:60–81.PubMedGoogle Scholar
  112. 112.
    Rhame FS, Streifel AJ, Kersey JHJ, McGlave PB. Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med 1984;76:42–52.PubMedCrossRefGoogle Scholar
  113. 113.
    Shlaes DM, Currie CA, Rotter G, Eanes M, Floyd R. Epidemiology of gentamicin-resistant, gram-negative bacillary colonization in a spinal cord injury unit. J Clin Microbiol 1983;18:227–235.PubMedGoogle Scholar
  114. 114.
    John JF Jr, Twitty JA. Plasmids as epidemiologic markers in nosocomial gram-negative bacilli: experience at a university and review of the literature. Rev Infect Dis 1986;8(5):693–704.PubMedCrossRefGoogle Scholar
  115. 115.
    Ieven M, Goossens H. Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev 1997;10(2):242–256.PubMedGoogle Scholar
  116. 116.
    Schluger NW, Rom WN. The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections. Am J Respir Crit Care Med 1995;152(1):11–16.PubMedCrossRefGoogle Scholar
  117. 117.
    Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88–93.PubMedCrossRefGoogle Scholar
  118. 118.
    Craven DE, Goularte TA, Make BJ. Contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia? Am Rev Respir Dis 1984;129:625–628.PubMedGoogle Scholar
  119. 119.
    Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792–796.PubMedGoogle Scholar
  120. 120.
    du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982;1:242–245.PubMedGoogle Scholar
  121. 121.
    Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991;19:942–949.PubMedCrossRefGoogle Scholar
  122. 122.
    Prod’hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994;120(8):653–662.CrossRefGoogle Scholar
  123. 123.
    Bonten MJ, Gaillard CA, van der G S, et al. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am J Respir Crit Care Med 1995;152(6 pt 1):1825–1834.PubMedCrossRefGoogle Scholar
  124. 124.
    Bonten MJ, Gaillard CA, De Leeuw PW, Stobberingh EE. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis 1997;24(3):309–319.PubMedCrossRefGoogle Scholar
  125. 125.
    MacCallum WG. Pathology of the pneumonia following influenza. JAMA 1919;72:720–723.CrossRefGoogle Scholar
  126. 126.
    Opie EL, Freeman AW, Blake FG, Small JC, Rivers TM. Pneumonia following influenza (at Camp Pike, Ark.). JAMA 1919;72:556–565.CrossRefGoogle Scholar
  127. 127.
    Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999;281(1):61–66.PubMedCrossRefGoogle Scholar
  128. 128.
    Introduction to Table V. Premature deaths, monthly mortality, and monthly physician contacts—United States. MMWR Morb Mortal Wkly Rep 1997;46(24):556–561.Google Scholar
  129. 129.
    Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985;313:1247–1251.PubMedCrossRefGoogle Scholar
  130. 130.
    Diamond LA, Lorber B. Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association. Am Rev Respir Dis 1984;129:876–878.PubMedGoogle Scholar
  131. 131.
    Karnad A, Alvarez S, Berk SL. Branhamella catarrhalis pneumonia in patients with immunoglobulin abnormalities. South Med J 1986;79:1360–1362.PubMedCrossRefGoogle Scholar
  132. 132.
    Sieber OF Jr, Fulginiti VA. Pseudomonas cepacia pneumonia in a child with chronic granulomatous disease and selective IgA deficiency. Acta Paediatr Scand 1976;65:519–520.PubMedCrossRefGoogle Scholar
  133. 133.
    Polsky B, Armstrong D. Infectious complications of neoplastic disease. Am J Infect Control 1985;13:199–209.PubMedCrossRefGoogle Scholar
  134. 134.
    Valdivieso M, Gil-extremera B, Zornoza J, Rodriquez V, Bodey GP. Gram-negative bacillary pneumonia in the compromised host. Medicine 1977;56:241–254.PubMedCrossRefGoogle Scholar
  135. 135.
    Huertas VE, Port FK, Rozas VV, Niederhuber JE. Pneumonia in recipients of renal allografts. Arch Surg 1976;111:162–166.PubMedCrossRefGoogle Scholar
  136. 136.
    Mermel LA, Maki DG. Bacterial pneumonia in solid organ transplantation. Semin Respir Infect 1990;5:10–29.PubMedGoogle Scholar
  137. 137.
    Rand KH, Pollard RB, Merigan TC. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 1978;298:951–953.PubMedCrossRefGoogle Scholar
  138. 138.
    Pennington JE, Reynolds HY, Carbone PP. Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med 1973;55:155–160.PubMedCrossRefGoogle Scholar
  139. 139.
    Donowitz GR, Harman C, Pope T, Stewart FM. The role of the chest roentgenogram in febrile neutropenic patients. Arch Intern Med 1991;151:701–704.PubMedCrossRefGoogle Scholar
  140. 140.
    Zornoza J, Goldman AM, Wallace S, Valdivieso M, Bodey GP. Radiologic features of gram-negative pneumonias in the neutropenic patient. AJR 1976;127:989–996.PubMedCrossRefGoogle Scholar
  141. 141.
    Levine SJ, White DA, Fels AOS. The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus. Am Rev Respir Dis 1990;141:89–93.PubMedCrossRefGoogle Scholar
  142. 142.
    Magnenat JL, Nicod LP, Auckenthaler R, Junod AF. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am Rev Respir Dis 1991;144:917–922.PubMedCrossRefGoogle Scholar
  143. 143.
    Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995;152(4 pt 1):1309–1315.PubMedCrossRefGoogle Scholar
  144. 144.
    Falco V, Fernandez de ST, Alegre J, et al. Bacterial pneumonia in HIV-infected patients: a prospective study of 68 episodes. Eur Respir J 1994;7(2):235–239.PubMedCrossRefGoogle Scholar
  145. 145.
    Boschini A, Smacchia C, Di FM, et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis 1996;23(1):107–113.PubMedCrossRefGoogle Scholar
  146. 146.
    Burack JH, Hahn JA, Saint-Maurice D, Jacobson MA. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy. Arch Intern Med 1994;154(22):2589–2596.PubMedCrossRefGoogle Scholar
  147. 147.
    Caiaffa WT, Graham NM, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1993;138(11):909–922.PubMedGoogle Scholar
  148. 148.
    Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987;82:900–906.PubMedCrossRefGoogle Scholar
  149. 149.
    Verghese A, Berk SL. Bacterial pneumonia in the elderly. Medicine 1983;62:271–285.PubMedCrossRefGoogle Scholar
  150. 150.
    Martin LF, Asher EF, Casey JM, Fry DE. Postoperative pneumonia. Determinants of mortality. Arch Surg 1984;119:379–383.PubMedCrossRefGoogle Scholar
  151. 151.
    Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994;96(4):313–320.PubMedCrossRefGoogle Scholar
  152. 152.
    Rello J, Rodriguez R, Jubert P, Alvarez B. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis 1996;23(4):723–728.PubMedCrossRefGoogle Scholar
  153. 153.
    Fein AM. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin Infect Dis 1999;28(4):726–729.PubMedCrossRefGoogle Scholar
  154. 154.
    Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine A. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31(2):347–382.PubMedCrossRefGoogle Scholar
  155. 155.
    Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31(2):383–421.PubMedCrossRefGoogle Scholar
  156. 156.
    Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163(7):1730–1754.PubMedCrossRefGoogle Scholar
  157. 157.
    Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997;157(15):1709–1718.PubMedCrossRefGoogle Scholar
  158. 158.
    Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 2000:717–742.Google Scholar
  159. 159.
    Barnes DJ, Naraqi S, Igo JD. The role of percutaneous lung aspiration in the bacteriological diagnosis of pneumonia in adults. Aust NZ J Med 1988;18:754–757.CrossRefGoogle Scholar
  160. 160.
    Torres A, Jimenez P, Puig de la Bellacasa J, Celis R, Gonzalez J, Gea J. Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia. Chest 1990;98:840–844.PubMedCrossRefGoogle Scholar
  161. 161.
    Palmer DL, Davidson M, Lusk R. Needle aspiration of the lung in complex pneumonias. Chest 1980;78:16–21.PubMedCrossRefGoogle Scholar
  162. 162.
    Garcia A, Roson B, Perez JL, et al. Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol 1999;37(3):709–714.PubMedGoogle Scholar
  163. 163.
    Vuori-Holopainen E, Peltola H. Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis 2001;32(5):715–726.PubMedCrossRefGoogle Scholar
  164. 164.
    Scott JA, Hall AJ. The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia. Chest 1999;116(6):1716–1732.PubMedCrossRefGoogle Scholar
  165. 165.
    Bartlett JG. Diagnostic accuracy of transtracheal aspiration: bacteriologic studies. Am Rev Respir Dis 1977;115(5):777–782.PubMedGoogle Scholar
  166. 166.
    Barrett-Connor E. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis 1971;103:845–848.PubMedGoogle Scholar
  167. 167.
    Levy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988;93(1):43–48.PubMedCrossRefGoogle Scholar
  168. 168.
    Woodhead MA, Arrowsmith J, Chamberlain-Webber R, Wooding S, Williams I. The value of routine microbial investigation in community-acquired pneumonia. Respir Med 1991;85(4):313–317.PubMedCrossRefGoogle Scholar
  169. 169.
    Gleckman R, DeVita J, Hibert D, Pelletier C, Martin R. Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 1988;26:846–849.PubMedGoogle Scholar
  170. 170.
    Drew WL. Value of sputum culture in diagnosis of pneumococcal pneumonia. J Clin Microbiol 1977;6:52–55.Google Scholar
  171. 171.
    Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000;31(4):869–874.PubMedCrossRefGoogle Scholar
  172. 172.
    Thorsteinsson SB, Musher DM, Fagan T. The diagnostic value of sputum culture in acute pneumonia. JAMA 1975;233:894–895.PubMedCrossRefGoogle Scholar
  173. 173.
    Bergmans DC, Bonten MJ, De Leeuw PW, Stobberingh EE. Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients. J Clin Microbiol 1997;35(3):796–798.PubMedGoogle Scholar
  174. 174.
    Murray PR, Washington JA, II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975;50:339–344.PubMedGoogle Scholar
  175. 175.
    Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987;135:426–432.PubMedGoogle Scholar
  176. 176.
    Kalin M, Lindberg AA, Tunevall G. Etiological diagnosis of bacterial pneumonia by gram stain and quantitative culture of expectorates. Leukocytes or alveolar macrophages as indicators of sample representativity. Scand J Infect Dis 1983;15:153–160.PubMedGoogle Scholar
  177. 177.
    Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 1977;6:396–399.PubMedGoogle Scholar
  178. 178.
    Rein MF, Gwaltney JM Jr, O’Brien WM, Jennings RH, Mandell GL. Accuracy of Gram’s stain in identifying pneumococci in sputum. JAMA 1978;239:2671–2673.PubMedCrossRefGoogle Scholar
  179. 179.
    Fine MJ, Orloff JJ, Rihs JD, et al. Evaluation of housestaff physicians’ preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med 1991;6:189–198.PubMedCrossRefGoogle Scholar
  180. 180.
    Ortqvist A, Kalin M, Lejdeborn L, Lundberg B. Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. Chest 1990;97:576–582.PubMedCrossRefGoogle Scholar
  181. 181.
    Sorensen J, Forsberg P, Hakanson E, et al. A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 1989;21(1):33–41.PubMedCrossRefGoogle Scholar
  182. 182.
    Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 1984;130:924–929.PubMedGoogle Scholar
  183. 183.
    Bregeon F, Papazian L, Thomas P, et al. Diagnostic accuracy of protected catheter sampling in ventilator-associated bacterial pneumonia. Eur Respir J 2000;16(5):969–975.PubMedCrossRefGoogle Scholar
  184. 184.
    Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995;152(1):231–240.PubMedCrossRefGoogle Scholar
  185. 185.
    Rouby JJ, Martin DL, Poete P, et al. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992;146(4):1059–1066.PubMedCrossRefGoogle Scholar
  186. 186.
    Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54(10):867–873.PubMedCrossRefGoogle Scholar
  187. 187.
    Torres A, Fabregas N, Ewig S, de la Bellacasa JP, Bauer TT, Ramirez J. Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references. Crit Care Med 2000;28(8):2799–2804.PubMedCrossRefGoogle Scholar
  188. 188.
    Kirtland SH, Corley DE, Winterbauer RH, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997;112(2):445–457.PubMedCrossRefGoogle Scholar
  189. 189.
    Marquette CH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995;151(6):1878–1888.PubMedCrossRefGoogle Scholar
  190. 190.
    Corley DE, Kirtland SH, Winterbauer RH, et al. Reproducibility of the histologic diagnosis of pneumonia among a panel of four pathologists: analysis of a gold standard. Chest 1997;112(2):458–465.PubMedCrossRefGoogle Scholar
  191. 191.
    Chastre J, Fagon JY, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988;85:499–506.PubMedCrossRefGoogle Scholar
  192. 192.
    Mertens AH, Nagler JM, Galdermans DI, Slabbynck HR, Weise B, Coolen D. Quality assessment of protected specimen brush samples by microscopic cell count. Am J Respir Crit Care Med 1998;157(4 pt 1):1240–1243.PubMedCrossRefGoogle Scholar
  193. 193.
    Jimenez P, Saldias F, Meneses M, Silva ME, Wilson MG, Otth L. Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest 1993;103(4):1023–1027.PubMedCrossRefGoogle Scholar
  194. 194.
    Rosati L, Leslie KO. Lung infections. In: Leslie KO, Wick M, eds. Practical pulmonary pathology: a diagnostic approach. Philadelphia: Churchill Livingstone, 2004.Google Scholar
  195. 195.
    Schwartzman WA. Infections due to Rochalimaea: the expanding clinical spectrum. Clin Infect Dis 1992;15(6):893–900.PubMedCrossRefGoogle Scholar
  196. 196.
    Wear DJ, Hadfield TL, Connor DH, et al. Periodic acid-Schiff reaction stains Mycobacterium tuberculosis, Mycobacterium leprae, Mycobacterium ulcerans, Mycobacterium chelonei (abscessus), and Mycobacterium kansasii. Arch Pathol Lab Med 1985;109:701–703.PubMedGoogle Scholar
  197. 197.
    Lowe RN, Azimi PH, McQuitty J. Acid-fast Actinomyces in a child with pulmonary actinomycosis. J Clin Microbiol 1980;12:124–126.PubMedGoogle Scholar
  198. 198.
    Jung WK. In vitro positive controls for histochemical stains of bacteria and fungi. Am J Clin Pathol 1985;84:342–345.PubMedGoogle Scholar
  199. 199.
    Chartrand SA, McCracken GH, Jr. Staphylococcal pneumonia in infants and children. Pediatr Infect Dis 1982;1:19–23.PubMedCrossRefGoogle Scholar
  200. 200.
    Enos WF, Beyer JC, Zimmet SM, Kiesel JA. Unilateral lobar pneumonia with empyema caused by Neisseria gonorrhoeae. South Med J 1980;73:266–267.PubMedCrossRefGoogle Scholar
  201. 201.
    Cockcroft DW, Stilwell GA. Lobar pneumonia caused by Mycoplasma pneumoniae. Can Med Assoc J 1981;124:1463–1468.PubMedGoogle Scholar
  202. 202.
    Heffron R. Pneumonia. 1 ed. Cambridge: Harvard University Press, 1939.Google Scholar
  203. 203.
    Loosli CG. Pathogenesis and pathology of lobar pneumonia. Lancet 1940;60:49–54.Google Scholar
  204. 204.
    Berry FB. Lobar pneumonia: analysis of 400 autopsies. Med Clin North Am 1920;4:571.Google Scholar
  205. 205.
    Löschcke H. Untersuchungen über die kruppose Pneumonie. Beitr Pathol Anat Allg Pathol 1931;53:249.Google Scholar
  206. 206.
    Graeser JB, Wu C, Robertson OH. Physical signs and roentgenographic findings in lobar pneumonia in adults. Arch Intern Med 1934;53:249.CrossRefGoogle Scholar
  207. 207.
    Blake FG, Howard ME, Hull WS. Artificial pneumothorax in the treatment of lobar pneumonia. JAMA 1935;105:1489.CrossRefGoogle Scholar
  208. 208.
    Winn WC Jr, Glavin FL, Perl DP, Craighead JE. Macroscopic pathology of the lungs in Legionnaires’ disease. Ann Intern Med 1979;90:548–551.PubMedCrossRefGoogle Scholar
  209. 209.
    Dietrich PA, Johnson RD, Fairbank JT, Walke JS. The chest radiograph in legionnaires’ disease. Radiology 1978;127:577–582.PubMedGoogle Scholar
  210. 210.
    Winn WC Jr, Glavin FL, Perl DP, et al. The pathology of legionnaires’ disease. Fourteen fatal cases from the 1977 outbreak in Vermont. Arch Pathol Lab Med 1978;102:344–350.PubMedGoogle Scholar
  211. 211.
    Winn WC Jr, Myerowitz RL. The pathology of the Legionella pneumonias. A review of 74 cases and the literature. Hum Pathol 1981;12:401–422.PubMedCrossRefGoogle Scholar
  212. 212.
    Hershey CO, Panaro V. Round pneumonia in adults. Arch Intern Med 1988;148:1155–1157.PubMedCrossRefGoogle Scholar
  213. 213.
    Yangco BG, Deresinski SC. Necrotizing or cavitating pneumonia due to Streptococcus pneumoniae: report of four cases and review of the literature. Medicine 1980;59:449–457.PubMedCrossRefGoogle Scholar
  214. 214.
    Kaye MG, Fox MJ, Bartlett JG, Braman SS, Glassroth J. The clinical spectrum of Staphylococcus aureus pulmonary infection. Chest 1990;97:788–792.PubMedCrossRefGoogle Scholar
  215. 215.
    Naraqi S, McDonnell G. Hematogenous staphylococcal pneumonia secondary to soft tissue infection. Chest 1981;79:173–175.PubMedCrossRefGoogle Scholar
  216. 216.
    Knight L, Fraser RG, Robson HG. Massive pulmonary gangrene: a severe complication of Klebsiella pneumonia. Can Med Assoc J 1975;112:196–198.PubMedGoogle Scholar
  217. 217.
    Goldstein JD, Godleski JJ, Balikian JP, Herman PG. Pathologic patterns of Serratia marcescens pneumonia. Hum Pathol 1982;13:479–484.PubMedCrossRefGoogle Scholar
  218. 218.
    Fetzer AE, Werner AS, Hagstrom JW. Pathologic features of pseudomonal pneumonia. Am Rev Respir Dis 1967;96:1121–1130.PubMedGoogle Scholar
  219. 219.
    Lewin S, Brettman LR, Goldstein EJ, et al. Legionnaires’ disease. A cause of severe abscess-forming pneumonia. Am J Med 1979;67:339–342.PubMedCrossRefGoogle Scholar
  220. 220.
    Dowling JN, Kroboth FJ, Karpf M, Yee RB, Pasculle AW. Pneumonia and multiple lung abscesses caused by dual infection with Legionella micdadei and Legionella pneumophila. Am Rev Respir Dis 1983;127:121–125.PubMedGoogle Scholar
  221. 221.
    Singh KP, Morris A, Lang SD, MacCulloch DM, Bremner DA. Clinically significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. N Z Med J 1988;101(859):813–816.PubMedGoogle Scholar
  222. 222.
    Shlaes DM, Lerner PI, Wolinsky E, Gopalakrishna KV. Infections due to Lancefield group F and related streptococci (S. milleri, S. anginosus). Medicine 1981;60(3):197–207.PubMedCrossRefGoogle Scholar
  223. 223.
    Shlaes DM, Lederman mm, Chmielewski R, Tweardy D, Krause G, Saffai C. Sputum elastin fibers and the diagnosis of necrotizing pneumonia. Chest 1984;85:763–766.PubMedCrossRefGoogle Scholar
  224. 224.
    Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974;56:202–207.PubMedCrossRefGoogle Scholar
  225. 225.
    Nusser RA, Tarkoff MP. Legionnaires disease causing adult respiratory distress syndrome. Survival and report of open lung biopsy. West J Med 1978;128:443–448.PubMedGoogle Scholar
  226. 226.
    Walsh JJ, Kelley J. Plasma cell pneumonia induced by Legionella pneumophila. Chest 1991;100:1170–1172.PubMedCrossRefGoogle Scholar
  227. 227.
    Kuhn C. Patterns of lung repair. A morphologist’s view. Chest 1991;99:11S–14S.PubMedGoogle Scholar
  228. 228.
    Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991;138:1257–1265.PubMedGoogle Scholar
  229. 229.
    Leslie KO, Mitchell J, Low R. Lung myofibroblasts. Cell Motil Cytoskeleton 1992;22:92–98.PubMedCrossRefGoogle Scholar
  230. 230.
    Adler KB, Low RB, Leslie KO, Mitchell J, Evans JN. Biology of disease. Contractile cells in normal and fibrotic lung. Lab Invest 1989;60:473–485.PubMedGoogle Scholar
  231. 231.
    Auerbach SH, Mims OM, Goodpasture EW. Pulmonary fibrosis secondary to pneumonia. Am J Pathol 1951;69–81.Google Scholar
  232. 232.
    Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14(4):801–807.PubMedCrossRefGoogle Scholar
  233. 233.
    Ort S, Ryan JL, Barden G, D’Esopo N. Pneumococcal pneumonia in hospitalized patients. Clinical and radiological presentations. JAMA 1983;249:214–218.PubMedCrossRefGoogle Scholar
  234. 234.
    Watanakunakorn C, Bailey TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992–1996. A detailed analysis of 108 cases. Arch Intern Med 1997;157(17):1965–1971.PubMedCrossRefGoogle Scholar
  235. 235.
    Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996;174(4):752–759.PubMedCrossRefGoogle Scholar
  236. 236.
    Loosli CG. The pathogenesis and pathology of experimental pneumonia in the monkey. J Exp Med 1942;76:79–95.PubMedCrossRefGoogle Scholar
  237. 237.
    Perlino CA. Laboratory diagnosis of pneumonia due to Streptococcus pneumoniae. J Infect Dis 1984;150:139–144.PubMedCrossRefGoogle Scholar
  238. 238.
    Valenti WM, Jenzer M, Bentley DW. Type-specific pneumococcal respiratory disease in the elderly and chronically ill. Am Rev Respir Dis 1978;117:233–238.PubMedGoogle Scholar
  239. 239.
    Perlino CA, Burleigh P. Penicillin-insensitive pneumococci: isolation from patients with pneumonia. South Med J 1979;72:20–22.PubMedCrossRefGoogle Scholar
  240. 240.
    Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev 2000;13(4):588–601.PubMedCrossRefGoogle Scholar
  241. 241.
    Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;52(2):229–246.PubMedCrossRefGoogle Scholar
  242. 242.
    Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States. The Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. N Engl J Med 2000;343(26):1917–1924.PubMedCrossRefGoogle Scholar
  243. 243.
    Moroney JF, Fiore AE, Harrison LH, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001;33(6):797–805.PubMedCrossRefGoogle Scholar
  244. 244.
    Merrill CW, Gwaltney JM Jr, Hendley JW, Sande MA. Rapid identification of pneumococci. Gram stain vs. the quellung reaction. N Engl J Med 1973;288:510–512.PubMedCrossRefGoogle Scholar
  245. 245.
    Isaacs RD. Necrotizing pneumonia in bacteraemic pneumococcal infection. Br J Dis Chest 1986;80:295–296.PubMedCrossRefGoogle Scholar
  246. 246.
    Leatherman JW, Iber C, Davies SF. Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria. Am Rev Respir Dis 1984;129:317–321.PubMedGoogle Scholar
  247. 247.
    Fruchtman SM, Gombert ME, Lyons HA. Adult respiratory distress syndrome as a cause of death in pneumococcal pneumonia. Report of ten cases. Chest 1983;83:598–601.PubMedCrossRefGoogle Scholar
  248. 248.
    Asmar BI, Thirumoorthi MC, Dajani AS. Pneumococcal pneumonia with pneumatocele formation. Am J Dis Child 1978;132:1091–1093.PubMedGoogle Scholar
  249. 249.
    Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1–7.PubMedCrossRefGoogle Scholar
  250. 250.
    Gray GC, Escamilla J, Hyams KC, Struewing JP, Kaplan EL, Tupponce AK. Hyperendemic Streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine. N Engl J Med 1991;325:92–97.PubMedCrossRefGoogle Scholar
  251. 251.
    Muller MP, Low DE, Green KA, et al. Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003;163(4):467–472.PubMedCrossRefGoogle Scholar
  252. 252.
    Mulla ZD. Group A streptococcal pneumonia. Arch Intern Med 2003;163(17):2101–2102.PubMedCrossRefGoogle Scholar
  253. 253.
    Molteni RA. Group A beta-hemolytic streptococcal pneumonia: clinical course and complications of management. Am J Dis Child 1977;131:1366–1371.PubMedGoogle Scholar
  254. 254.
    Gerber GJ, Farmer WC, Fulkerson LL. b-hemolytic streptococcal pneumonia following influenza. JAMA 1978;240:242–243.PubMedCrossRefGoogle Scholar
  255. 255.
    Keefer CS, Rantz LA, Rammelkamp CH. Hemolytic streptococcal pneumonia and empyema: a study of 55 cases with special reference to treatment. Ann Intern Med 1941;14:1533–1550.CrossRefGoogle Scholar
  256. 256.
    Basiliere JL, Bistrong HW, Spence WF. Streptococcal pneumonia. Recent outbreaks in military recruit populations. Am J Med 1968;44:580–589.PubMedCrossRefGoogle Scholar
  257. 257.
    Outbreak of group A streptococcal pneumonia among Marine Corps recruits—California, November 1–December 20, 2002. MMWR Morb Mortal Wkly Rep 2003;52(6):106–109.Google Scholar
  258. 258.
    Trujillo M, McCracken GH, Jr. Prolonged morbidity in children with group A beta-hemolytic streptococcal pneumonia. Pediatr Infect Dis J 1994;13(5):411–412.PubMedCrossRefGoogle Scholar
  259. 259.
    Roy S, Kaplan EL, Rodriguez B, et al. A family cluster of five cases of group A streptococcal pneumonia. Pediatrics 2003;112(1 pt 1):e61–e65.PubMedCrossRefGoogle Scholar
  260. 260.
    Cecil RL. Pneumonia and empyema at Camp Upton, NY. Med Clin North Am 1918;2:567.Google Scholar
  261. 261.
    MacCallum WG. Pathology of epidemic streptococcal bronchopneumonia in army camps. JAMA 1918;71:704.CrossRefGoogle Scholar
  262. 262.
    Goodpasture EW. Bronchopneumonia due to hemolytic streptococci following influenza. JAMA 1919;72:724–725.CrossRefGoogle Scholar
  263. 263.
    McIntyre HD, Armstrong JG, Mitchell CA. Streptococcus pyogenes pneumonia with abscess formation. Aust NZ J Med 1989;19:248–249.CrossRefGoogle Scholar
  264. 264.
    McCormick BA, Wilson IH, Berrisford RG. Bronchopleural fistula complicating group A beta-haemolytic streptococcal pneumonia. Use of a Fogarty embolectomy catheter for selective bronchial blockade. Intensive Care Med 1999;25(5):535–537.PubMedCrossRefGoogle Scholar
  265. 265.
    Kevy SV, Lowe BA. Streptococcal pneumonia and empyema in childhood. N Engl J Med 1961;264:738.PubMedCrossRefGoogle Scholar
  266. 266.
    Lerner PI, Gopalakrishna KV, Wolinsky E, et al. Group B Streptococcus bacteremia in adults: analysis of 32 cases and review of the literature. Medicine 1977;56:457–473.PubMedCrossRefGoogle Scholar
  267. 267.
    Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 2001;33(4):556–561.PubMedCrossRefGoogle Scholar
  268. 268.
    Trivalle C, Martin E, Martel P, Jacque B, Menard JF, Lemeland JF. Group B streptococcal bacteraemia in the elderly. J Med Microbiol 1998;47(7):649–652.PubMedCrossRefGoogle Scholar
  269. 269.
    Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993;328(25):1807–1811.PubMedCrossRefGoogle Scholar
  270. 270.
    Verghese A, Berk SL, Boelen LJ, Smith JK. Group B streptococcal pneumonia in the elderly. Arch Intern Med 1982;142:1642–1645.PubMedCrossRefGoogle Scholar
  271. 271.
    Munoz P, Llancaqueo A, Rodriguez-Creixems M, Pelaez T, Martin L, Bouza E. Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 1997;157(2):213–216.PubMedCrossRefGoogle Scholar
  272. 272.
    Larppanichpoonphol P, Watanakunakorn C. Group B streptococcal bacteremia in nonpregnant adults at a community teaching hospital. South Med J 2001;94(12):1206–1211.PubMedGoogle Scholar
  273. 273.
    Perovic O, Crewe-Brown HH, Khoosal M, Karstaedt AS. Invasive group B streptococcal disease in nonpregnant adults. Eur J Clin Microbiol Infect Dis 1999;18(5):362–364.PubMedCrossRefGoogle Scholar
  274. 274.
    Stamm AM, Cobbs CG. Group C streptococcal pneumonia: report of a fatal case and review of the literature. Rev Infect Dis 1980;2:889–898.PubMedCrossRefGoogle Scholar
  275. 275.
    Bradley SF, Gordon JJ, Baumgartner DD, Marasco WA, Kauffman CA. Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis 1991;13(2):270–280.PubMedCrossRefGoogle Scholar
  276. 276.
    Schwartz RH, Shulman ST. Group C and group G streptococci. In-office isolation from children and adolescents with pharyngitis. Clin Pediatr (Phila) 1986;25(10):496–502.CrossRefGoogle Scholar
  277. 277.
    Mohr DN, Feist DJ, Washington JA, Hermans PE. Infections due to group C streptococci in man. Am J Med 1979;66:450–456.PubMedCrossRefGoogle Scholar
  278. 278.
    Siefkin AD, Peterson DL, Hansen B. Streptococcus equisimilis pneumonia in a compromised host. J Clin Microbiol 1983;17:386–388.PubMedGoogle Scholar
  279. 279.
    Rose HD, Allen JR, Witte G. Streptococcus zooepidemicus (group C) pneumonia in a human. J Clin Microbiol 1980;11:76–78.PubMedGoogle Scholar
  280. 280.
    Dolinski SY, Jones PG, Zabransky RJ, Rasansky M. Group C streptococcal pleurisy and pneumonia: a fulminant case and review of the literature. Infection 1990;18:239–241.PubMedCrossRefGoogle Scholar
  281. 281.
    de Miguel J, Collazos J, Echeverria J, Egurbide V, Ayarza R. Group C streptococcal pneumonia and aneurysm infection. Chest 1993;104(5):1644.PubMedCrossRefGoogle Scholar
  282. 282.
    Ancona RJ, Thompson TR, Ferrieri P. Group G streptococcal pneumonia and sepsis in a newborn infant. J Clin Microbiol 1979;10:758–759.PubMedGoogle Scholar
  283. 283.
    Jerng JS, Hsueh PR, Teng LJ, Lee LN, Yang PC, Luh KT. Empyema thoracis and lung abscess caused by viridans streptococci. Am J Respir Crit Care Med 1997;156(5):1508–1514.PubMedCrossRefGoogle Scholar
  284. 284.
    Wong CA, Donald F, Macfarlane JT. Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients. Thorax 1995;50(10):1093–1096.PubMedCrossRefGoogle Scholar
  285. 285.
    Porta G, Rodriguez-Carballeira M, Gomez L, et al. Thoracic infection caused by Streptococcus milleri. Eur Respir J 1998;12(2):357–362.PubMedCrossRefGoogle Scholar
  286. 286.
    Koshi G, John L. Lancefield group F streptococci causing liver abscess and empyema. Indian J Med Res 1971;59:45–49.PubMedGoogle Scholar
  287. 287.
    Sarkar TK, Murarka RS, Gilardi GL. Primary streptococcus viridans pneumonia. Chest 1989;96:831–834.PubMedCrossRefGoogle Scholar
  288. 288.
    Pratter MR, Irwin RS. Viridans streptococcal pulmonary parenchymal infections. JAMA 1980;243:2515–2517.PubMedCrossRefGoogle Scholar
  289. 289.
    Berk SL, Verghese A, Holtsclaw SA, Smith JK. Enterococcal pneumonia. Occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding. Am J Med 1983;74(1):153–154.PubMedCrossRefGoogle Scholar
  290. 290.
    Eliopoulos GM, Wennersten C, Reiszner E, Goldmann D, Moellering RC, Jr. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 1988;32,10:1528–1532.PubMedCrossRefGoogle Scholar
  291. 291.
    Rice LB. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 2001;7(2):183–187.PubMedCrossRefGoogle Scholar
  292. 292.
    Rello J, Quintana E, Ausina V, Puzo C, Net A, Prats G. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 1990;142:1320–1324.PubMedCrossRefGoogle Scholar
  293. 293.
    Woodhead MA, Radvan J, Macfarlane JT. Adult community-acquired staphylococcal pneumonia in the antibiotic era: a review of 61 cases. Q J Med 1987;64:783–790.PubMedGoogle Scholar
  294. 294.
    Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958;2:233–236.PubMedCrossRefGoogle Scholar
  295. 295.
    Fisher AM, Trever RW, Curtin JA, Schultze G, Miller DF. Staphylococcal pneumonia. A review of 21 cases in adults. N Engl J Med 1958;258:919–928.PubMedCrossRefGoogle Scholar
  296. 296.
    Espersen F, Gabrielsen J. Pneumonia due to Staphylococcus aureus during mechanical ventilation. J Infect Dis 1981;144:19–23.PubMedCrossRefGoogle Scholar
  297. 297.
    Stutman HR, Marks MI. Pulmonary infections in children with cystic fibrosis. Semin Respir Infect 1987;2:166–176.PubMedGoogle Scholar
  298. 298.
    McGarry T, Giosa R, Rohman M, Huang CT. Pneumatocele formation in adult pneumonia. Chest 1987;92:717–720.PubMedCrossRefGoogle Scholar
  299. 299.
    Chonmaitree T, Powell KR. Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience, 1962—1980. Clin Pediatr (Phila) 1983;22:414–419.CrossRefGoogle Scholar
  300. 300.
    Gallis HA. Subacute staphylococcal pneumonia in a renal transplant recipient. Am Rev Respir Dis 1975;112:109–112.PubMedGoogle Scholar
  301. 301.
    Musher DM, McKenzie SO. Infections due to Staphylococcus aureus. Medicine 1977;56:383–409.PubMedCrossRefGoogle Scholar
  302. 302.
    Watanakunakorn C. Bacteremic Staphylococcus aureus pneumonia. Scand J Infect Dis 1987;19:623–627.PubMedCrossRefGoogle Scholar
  303. 303.
    Massanari RM, Pfaller MA, Wakefield DS, et al. Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections. J Infect Dis 1988;158:702–709.PubMedCrossRefGoogle Scholar
  304. 304.
    Souhami L, Feld R, Tuffnell PG, Feller T. Micrococcus luteus pneumonia: a case report and review of the literature. Med Pediatr Oncol 1979;7:309–314.PubMedCrossRefGoogle Scholar
  305. 305.
    Causey WA, Lee R. Nocardiosis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Infections of the nervous system, part III. Handbk Clin Neurol 1978;35:517–530.Google Scholar
  306. 306.
    Chandler FW, Watts JC. Pathologic diagnosis of fungal infections. 1 ed. Chicago: ASCP Press, 1987.Google Scholar
  307. 307.
    Smego RAJ, Gallis HA. The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis 1984;6:164–180.PubMedCrossRefGoogle Scholar
  308. 308.
    Krick JA, Stinson EB, Remington JS. Nocardia infection in heart transplant patients. Ann Intern Med 1975;82:18–26.PubMedCrossRefGoogle Scholar
  309. 309.
    Simpson GL, Stinson EB, Egger MJ, Remington JS. Nocardial infections in the immunocompromised host: a detailed study in a defined population. Rev Infect Dis 1981;3(3):492–507.PubMedCrossRefGoogle Scholar
  310. 310.
    Young LS, Armstrong D, Blevins A, Lieberman P. Nocardia asteroides infection complicating neoplastic disease. Am J Med 1971;50:356–367.PubMedCrossRefGoogle Scholar
  311. 311.
    Casale TB, Macher AM, Fauci AS. Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. South Med J 1984;77:274–275.PubMedCrossRefGoogle Scholar
  312. 312.
    Jonsson S, Wallace RJ Jr, Hull SI, Musher DM. Recurrent Nocardia pneumonia in an adult with chronic granulomatous disease. Am Rev Respir Dis 1986;133:932–934.PubMedGoogle Scholar
  313. 313.
    Burbank B, Morrione TG, Cutler SS. Pulmonary alveolar proteinosis and nocardiosis. Am J Med 1960;28:1002–1007.PubMedCrossRefGoogle Scholar
  314. 314.
    Carlsen ET, Hill RB, Rowlands DT. Nocardiosis and pulmonary alveolar proteinosis. Ann Intern Med 1964;60:275–281.PubMedCrossRefGoogle Scholar
  315. 315.
    Clague HW, Harth M, Hellyer D. Septic arthritis due to Nocardia asteroides in association with pulmonary alveolar proteinosis. J Rheumatol 1982;9:469–472.PubMedGoogle Scholar
  316. 316.
    McNeil MM, Brown JM, Georghiou PR, Allworth AM, Blacklock ZM. Infections due to Nocardia transvalensis: clinical spectrum and antimicrobial therapy. Clin Infect Dis 1992;15(3):453–463.PubMedCrossRefGoogle Scholar
  317. 317.
    Stevens DA. Clinical and clinical laboratory aspects of nocardial infection. J Hyg (Lond) 1983;91:377–384.CrossRefGoogle Scholar
  318. 318.
    Palmer DL, Harvey RL, Wheeler JK. Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine 1974;53:391–401.PubMedCrossRefGoogle Scholar
  319. 319.
    Berd D. Nocardia brasiliensis infection in the United States: A report of nine cases and a review of the literature. Am J Clin Pathol 1973;60:254–258.PubMedGoogle Scholar
  320. 320.
    Beaman BL, Burnside J, Edward B. Nocardia infections in the United States, 1972–1974. J Infect Dis 1976;134:286–289.PubMedCrossRefGoogle Scholar
  321. 321.
    Stropes L, Bartlett M, White A. Multiple recurrences of Nocardia pneumonia. Am J Med Sci 1980;280:119–122.PubMedCrossRefGoogle Scholar
  322. 322.
    Curry WA. Human nocardiosis: a clinical review with selected case reports. Arch Intern Med 1980;140:818–826.PubMedCrossRefGoogle Scholar
  323. 323.
    Boudoulas O, Camisa C. Nocardia asteroides infection with dissemination to skin and joints. Arch Dermatol 1985;121:898–900.PubMedCrossRefGoogle Scholar
  324. 324.
    Garty BZ, Stark H, Yaniv I. Pulmonary nocardiosis in a child with systemic lupus erythematosus. Pediatr Infect Dis 1985;4:66–68.PubMedCrossRefGoogle Scholar
  325. 325.
    Neu HC, Silva M, Hazen E, Rosenheim SH. Necrotizing nocardial pneumonitis. Ann Intern Med 1967;66(2):274–284.PubMedCrossRefGoogle Scholar
  326. 326.
    Frazier AR, Rosenow EC, Roberts GD. Nocardiosis: a review of 25 cases occurring during 24 months. Mayo Clin Proc 1975;50:657–663.PubMedGoogle Scholar
  327. 327.
    Adams HG, Beeler BA, Wann LS. Synergistic action of trimethoprim and sulfamethoxazole for Nocardia asteroides: Efficacious therapy in five patients. Am J Med Sci 1984;287:8–12.PubMedCrossRefGoogle Scholar
  328. 328.
    Kamat BR, Dvorak AM. The electron microscopic appearance of Nocardia asteroides in human lung tissue. Arch Pathol Lab Med 1984;108:862–864.PubMedGoogle Scholar
  329. 329.
    Robboy SJ, Vickery AL Jr. Tinctorial and morphologic properties distinguishing actinomycosis and nocardiosis. N Engl J Med 1970;282(11):593–596.PubMedCrossRefGoogle Scholar
  330. 330.
    Woolsorters’ disease in Bradford. Lancet 1880;1:819–820.Google Scholar
  331. 331.
    Bell JH. “Woolsorters’ disease.” Lancet 1880;1:871–873.CrossRefGoogle Scholar
  332. 332.
    Bell JH. “Woolsorters’ disease.” Lancet 1880;1:909–911.CrossRefGoogle Scholar
  333. 333.
    Smith IM. A brief review of anthrax in domestic animals. Postgrad Med J 1973;49:571–572.PubMedCrossRefGoogle Scholar
  334. 334.
    Gold H. Anthrax. A report of 117 cases. Arch Intern Med 1955;96:387–396.CrossRefGoogle Scholar
  335. 335.
    Kaya A, Tasyaran MA, Erol S, Ozkurt Z, Ozkan B. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002;21(4):258–261.PubMedCrossRefGoogle Scholar
  336. 336.
    Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory route. J Path Bact 1957;73:485–494.CrossRefGoogle Scholar
  337. 337.
    Plotkin SA, Brachman PS, Utell M, et al. An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features. Am J Med 1960;29:992–1001.PubMedCrossRefGoogle Scholar
  338. 338.
    Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7(6):933–944.PubMedCrossRefGoogle Scholar
  339. 339.
    Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. Quantitative pathology of inhalational anthrax i: quantitative microscopic findings. Mod Pathol 2001;14(5):482–495.PubMedCrossRefGoogle Scholar
  340. 340.
    Guidi-Rontani C, Weber-Levy M, Labruyere E, Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 1999;31(1):9–17.PubMedCrossRefGoogle Scholar
  341. 341.
    Guarner J, Jernigan JA, Shieh WJ, et al. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol 2003;163(2):701–709.PubMedCrossRefGoogle Scholar
  342. 342.
    Pezard C, Berche P, Mock M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 1991;59:3472–3477.PubMedGoogle Scholar
  343. 343.
    Cowdery JS. Primary pulmonary anthrax with septicemia. Arch Pathol 1947;43:396–399.Google Scholar
  344. 344.
    Dalldorf FG, Kaufmann AF, Brachman PS. Woolsorters’ disease. An experimental model. Arch Pathol 1971;92:418–426.PubMedGoogle Scholar
  345. 345.
    Stephen J. Anthrax toxin. Pharmacol Ther 1981;12:501–513.PubMedCrossRefGoogle Scholar
  346. 346.
    Cherry WB, Moody MD. Fluorescent-antibody techniques in diagnostic bacteriology. Bacteriol Rev 1965;29:222–250.Google Scholar
  347. 347.
    Berg R, Chmel H, Mayo J, Armstrong D. Corynebacterium equi infection complicating neoplastic disease. Am J Clin Pathol 1977;68:73–77.PubMedGoogle Scholar
  348. 348.
    Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin Microbiol Rev 1990;3(3):227–246.PubMedGoogle Scholar
  349. 349.
    Harvey RL, Sunstrum JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991;13(1):139–145.PubMedCrossRefGoogle Scholar
  350. 350.
    van Etta LL, Filice GA, Ferguson RM, Gerding DN. Corynebacterium equi: a. review of 12 cases of human infection. Rev Infect Dis 1983;5(6):1012–1018.PubMedCrossRefGoogle Scholar
  351. 351.
    MacGregor JH, Samuelson WM, Sane DC, Godwin JD. Opportunistic lung infection caused by Rhodococcus (Corynebacterium) equi. Radiology 1986;160:83–84.PubMedGoogle Scholar
  352. 352.
    Jones MR, Neale TJ, Say PJ, Home JG. Rhodococcus equi: an emerging opportunistic pathogen? Aust NZ J Med 1989;19:103–107.CrossRefGoogle Scholar
  353. 353.
    Doig C, Gill MJ, Church DL. Rhodococcus equi—an easily missed opportunistic pathogen. Scand J Infect Dis 1991;23:1–6.PubMedCrossRefGoogle Scholar
  354. 354.
    Carpenter JL, Blom J. Corynebacterium equi pneumonia in a patient with Hodgkin’s disease. Am Rev Respir Dis 1976;114:235–239.PubMedGoogle Scholar
  355. 355.
    Golub B, Falk G, Spink WW. Lung abscess due to Corynebacterium equi. Ann Intern Med 1967;66:1174–1177.PubMedCrossRefGoogle Scholar
  356. 356.
    Sarnies JH, Hathaway BN, Echols RM, Veazey JM Jr, Pilon VA. Lung abscess due to Corynebacterium equi. Report of the first case in a patient with acquired immune deficiency syndrome. Am J Med 1986;80(4):685–688.CrossRefGoogle Scholar
  357. 357.
    Weingarten JS, Huang DY, Jackman JD Jr. Rhodococcus equi pneumonia. An unusual early manifestation of the acquired immunodeficiency syndrome (AIDS). Chest 1988;94:195–196.PubMedCrossRefGoogle Scholar
  358. 358.
    Emmons W, Reichwein B, Winslow DL. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case. Rev Infect Dis 1991;13:91–96.PubMedCrossRefGoogle Scholar
  359. 359.
    Prescott JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 1991;4(1):20–34.PubMedGoogle Scholar
  360. 360.
    Barton MD, Hughes KL. Ecology of Rhodococcus equi. Vet Microbiol 1984;9:65–76.PubMedCrossRefGoogle Scholar
  361. 361.
    Savdie E, Pigott P, Jennis F. Lung abscess due to Corynebacterium equi in a renal transplant recipient. Med J Aust 1977;1:817–819.PubMedGoogle Scholar
  362. 362.
    Lebar WD, Pensler MI. Pleural effusion due to Rhodococcus equi. J Infect Dis 1986;154:919–920.PubMedCrossRefGoogle Scholar
  363. 363.
    Muller F, Schaal KP, von Graevenitz A, et al. Characterization of Rhodococcus equi-like bacterium isolated from a wound infection in a noncompromised host. J Clin Microbiol 1988;26(4):618–620.PubMedGoogle Scholar
  364. 364.
    Takai S, Michizoe T, Matsumura K, et al. Correlation of in vitro properties of Rhodococcus (Corynebacterium) equi with virulence for mice. Microbiol Immunol 1985;29:1175–1184.PubMedGoogle Scholar
  365. 365.
    Waters BL. Pathology of culture-proven JK Corynebacterium pneumonia. An autopsy case report. Am J Clin Pathol 1989;91(5):616–619.PubMedGoogle Scholar
  366. 366.
    McNaughton RD, Villanueva RR, Donnelly R, Freedman J, Nawrot R. Cavitating pneumonia caused by Corynebacterium group JK. J Clin Microbiol 1988;26:2216–2217.PubMedGoogle Scholar
  367. 367.
    Miller RA, Rompalo A, Coyle MB. Corynebacterium pseudodiphtheriticum pneumonia in an immunologically intact host. Diagn Microbiol Infect Dis 1986;4(2):165–171.PubMedCrossRefGoogle Scholar
  368. 368.
    Jacobs NF Jr, Perlino CA. “Diphtheroid” pneumonia. South Med J 1979;72(4):475–476.PubMedCrossRefGoogle Scholar
  369. 369.
    Keslin MH, McCoy EL, McCusker JJ, Lutch JS. Corynebacterium pseudotuberculosis. A new cause of infectious and eosinophilic pneumonia. Am J Med 1979;67:228–231.PubMedCrossRefGoogle Scholar
  370. 370.
    Berenguer J, Solera J, Diaz MD, Moreno S, Lopez-Herce JA, Bouza E. Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis 1991;13:115–119.PubMedCrossRefGoogle Scholar
  371. 371.
    Whitelock-Jones L, Carswell J, Rasmussen K. Listeria pneumonia. A case report. S Afr Med J 1989;75:188–189.PubMedGoogle Scholar
  372. 372.
    Jonsson S, Clarridge J, Young EJ. Necrotizing pneumonia and empyema caused by Bacillus cereus and Clostridium bifermentans. Am Rev Respir Dis 1983;127(3):357–359.PubMedGoogle Scholar
  373. 373.
    Bekemeyer WB, Zimmerman GA. Life-threatening complications associated with Bacillus cereus pneumonia. Am Rev Respir Dis 1985;131:466–469.PubMedGoogle Scholar
  374. 374.
    Querol JM, Manresa F, Izquierdo J, Cisnal M. Lactobacillus pneumonia in a patient with oesophageal carcinoma. Eur Respir J 1989;2:589–591.PubMedGoogle Scholar
  375. 375.
    Johnson AP, Uttley AH, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev 1990;3(3):280–291.PubMedGoogle Scholar
  376. 376.
    Schiff MJ, Kaplan MH. Rothia dentocariosa pneumonia in an immunocompromised patient. Lung 1987;165:279–282.PubMedCrossRefGoogle Scholar
  377. 377.
    Galpin JE, Chow AW, Yoshikawa TT, Guze LB. Meningococcal pneumonia. Am J Med Sci 1975;269:247–250.PubMedCrossRefGoogle Scholar
  378. 378.
    Olson RW, Hodges GR. Measles pneumonia. Bacterial suprainfection as a complicating factor. JAMA 1975;232:363–365.PubMedCrossRefGoogle Scholar
  379. 379.
    Barnes RV, Dopp AC, Gelberg HJ, Silva J Jr. Neisseria meningitidis: a cause of nosocomial pneumonia. Am Rev Respir Dis 1975;111:229–231.PubMedGoogle Scholar
  380. 380.
    Rose HD, Lenz IE, Sheth NK. Meningococcal pneumonia. A source of nosocomial infection. Arch Intern Med 1981;141:575–577.PubMedCrossRefGoogle Scholar
  381. 381.
    Irwin RS, Woelk WK, Coudon WL, III. Primary meningococcal pneumonia. Ann Intern Med 1975;82:493–498.PubMedCrossRefGoogle Scholar
  382. 382.
    Yee NM, Katz M, Neu HC. Meningitis, pneumonitis, and arthritis caused by Neisseria meningitidis group Y. JAMA 1975;232:1354–1355.PubMedCrossRefGoogle Scholar
  383. 383.
    Hersh JH, Gold R, Lepow ML. Meningococcal group Y pneumonia in an adolescent female. Pediatrics 1979;64:222–224.PubMedGoogle Scholar
  384. 384.
    Brandstetter RD, Blair RJ, Roberts RB. Neisseria meningitidis serogroup W 135 disease in adults. JAMA 1981;246:2060–2061.PubMedCrossRefGoogle Scholar
  385. 385.
    Witt D, Olans RN. Bacteremic W-135 meningococcal pneumonia. Am Rev Respir Dis 1982;125:255–257.PubMedGoogle Scholar
  386. 386.
    Sacks HS. Meningococcal pneumonia and empyema. Am J Med 1986;80:290–291.PubMedCrossRefGoogle Scholar
  387. 387.
    Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med 1986;104:655.PubMedCrossRefGoogle Scholar
  388. 388.
    Boyce JM, Taylor MR, Mitchell EB Jr, Knapp JS. Nosocomial pneumonia caused by a glucose-metabolizing strain of Neisseria cinerea. J Clin Microbiol 1985;21(1):1–3.PubMedGoogle Scholar
  389. 389.
    Gris P, Vincke G, Delmez JP, Dierckx JP. Neisseria sicca pneumonia and bronchiectasis. Eur Respir J 1989;2:685–687.PubMedGoogle Scholar
  390. 390.
    Gilrane T, Tracy JD, Greenlee RM, Schelpert JW, Brandstetter RD. Neisseria sicca pneumonia. Report of two cases and review of the literature. Am J Med 1985;78:1038–1040.PubMedCrossRefGoogle Scholar
  391. 391.
    Mays BB, Thomas GD, Leonard JS Jr, Southern PM Jr, Pierce AK, Sanford JP. Gram-negative bacillary necrotizing pneumonia: a bacteriologic and histopathologic correlation. J Infect Dis 1969;120:687–697.PubMedCrossRefGoogle Scholar
  392. 392.
    Phair JP, Bassaris HP, Williams JE, Metzger E. Bacteremic pneumonia due to gram-negative bacilli. Arch Intern Med 1983;143:2147–2149.PubMedCrossRefGoogle Scholar
  393. 393.
    Karnad A, Alvarez S, Berk SL. Pneumonia caused by gram-negative bacilli. Am J Med 1985;79:61–67.PubMedCrossRefGoogle Scholar
  394. 394.
    Pierce AK, Sanford JP. Aerobic gram-negative bacillary pneumonias. Am Rev Respir Dis 1974;110:647–658.PubMedGoogle Scholar
  395. 395.
    LaForce FM. Hospital-acquired gram-negative rod pneumonias: an overview. Am J Med 1981;70:664–669.PubMedCrossRefGoogle Scholar
  396. 396.
    Tillotson JR, Lerner AM. Pneumonias caused by gram negative bacilli. Medicine 1966;45:65–76.PubMedCrossRefGoogle Scholar
  397. 397.
    Friedländer C. Über die Schizomyceten bei der acuten fibrösen Pneumonie. Virchows Arch A Pathol Anat Histopathol 1882;87:319.CrossRefGoogle Scholar
  398. 398.
    Zander R. Ausgedehnte Endemie von Lungenentzündungen durch Infektion mid Friedländerschen Pneumobazillen unter Zivilarbeitern. Dtsch Med Wochenschr 1919;45:1180.CrossRefGoogle Scholar
  399. 399.
    Erasmus LD. Friedländer bacillus infection of the lung. Q J Med 1956;25:507–521.PubMedGoogle Scholar
  400. 400.
    Belk WP Pulmonary infections by Friedländer’s bacillus. J Infect Dis 1926;38:115.CrossRefGoogle Scholar
  401. 401.
    Olcott CT. Pneumonia due to Friedländer’s bacillus. Arch Pathol 1933;16:471.Google Scholar
  402. 402.
    Bullowa JGM, Chess J, Friedman NB. Pneumonia due to Bacillus friedländeri. Arch Intern Med 1937;60:735–752.CrossRefGoogle Scholar
  403. 403.
    Unger JD, Rose HD, Unger GF. Gram-negative pneumonia. Radiology 1973;107:283–291.PubMedGoogle Scholar
  404. 404.
    Holmes RB. Friedländer’s pneumonia. AJR 1956;75:728–745.Google Scholar
  405. 405.
    Fremmel F, Henrichsen KJ, Sweany HC. Pulmonary infections by Friedländer’s bacillus (Bac. mucosus capsulatus). Ann Intern Med 1932;5:886.CrossRefGoogle Scholar
  406. 406.
    Smith SM, Digori JT, Eng RH. Epidemiology of Klebsiella antibiotic resistance and serotypes. J Clin Microbiol 1982;16:868–873.PubMedGoogle Scholar
  407. 407.
    Solomon S. Chronic Friedländer infections of the lungs. Report of seventeen cases and observations on therapy with sulfapyridine and sulfanilamide. JAMA 1940;115:1527–1536.CrossRefGoogle Scholar
  408. 408.
    Collins LH, Jr. Chronic pulmonary infection due to the Friedländer bacillus. Arch Intern Med 1936;58:235.CrossRefGoogle Scholar
  409. 409.
    Tillotson JR, Lerner AM. Characteristics of pneumonias caused by Escherichia coli. N Engl J Med 1967;277:115–122.PubMedCrossRefGoogle Scholar
  410. 410.
    Jonas M, Cunha BA. Bacteremic Escherichia coli pneumonia. Arch Intern Med 1982;142:2157–2159.PubMedCrossRefGoogle Scholar
  411. 411.
    Berk SL, Neumann P, Holtsclaw S, Smith JK. Escherichia coli pneumonia in the elderly with reference to the role of E. coli K1 capsular polysaccharide antigen. Am J Med 1982;72:899–902.PubMedCrossRefGoogle Scholar
  412. 412.
    Broughton WA, Kirkpatrick MB. Acute necrotizing pneumonia caused by Enterobacter cloacae. South Med J 1988;81:1061–1062.PubMedCrossRefGoogle Scholar
  413. 413.
    Svarva PL, Lyng RV, Maeland JA. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime. Scand J Infect Dis 1985;17:387–391.PubMedGoogle Scholar
  414. 414.
    Yu VL. Serratia marcescens. Historical perspective and clinical review. N Engl J Med 1979;300:887–893.PubMedCrossRefGoogle Scholar
  415. 415.
    Sanders CV Jr, Luby JP, Johanson WG, Barnett JA, Sanford JP. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med 1970;73:15–21.PubMedCrossRefGoogle Scholar
  416. 416.
    Balikian JP, Herman PG, Godleski JJ. Serratia pneumonia. Radiology 1980;137:309–311.PubMedGoogle Scholar
  417. 417.
    Carlon GC, Dickinson PC, Goldiner PL, Turnbull AD, Howland WS. Serratia marcescens pneumonia. Arch Surg 1977;112:1220–1224.PubMedCrossRefGoogle Scholar
  418. 418.
    Reed W. Association of Proteus vulgaris and Diplococcus lanceolatus in a case of croupous pneumonia. Hopkins Hosp Bull 1894;5:24.Google Scholar
  419. 419.
    Tillotson JR, Lerner AM. Characteristics of pneumonias caused by Bacillus proteus. Ann Intern Med 1968;68:287–294.PubMedCrossRefGoogle Scholar
  420. 420.
    Lysy J, Werczberger A, Globus M, Chowers I. Pneumatocele formation in a patient with Proteus mirabilis pneumonia. Postgrad Med J 1985;61(713):255–257.PubMedCrossRefGoogle Scholar
  421. 421.
    Seriff NS. Lobar pneumonia due to Proteus infection in a previously healthy adult. Am J Med 1969;46:480–488.PubMedCrossRefGoogle Scholar
  422. 422.
    Solberg CO, Matsen JM. Infections with providence bacilli. A clinical and bacteriologic study. Am J Med 1971;50:241–246.PubMedCrossRefGoogle Scholar
  423. 423.
    Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of Salmonella infections. Medicine 1987;66(5):349–388.PubMedCrossRefGoogle Scholar
  424. 424.
    Neva F. Pulmonary involvement in typhoid and paratyphoid fevers. Ann Intern Med 1950;33:83–89.PubMedCrossRefGoogle Scholar
  425. 425.
    Stuart BM, Pullen RL. Typhoid: clinical analysis of three hundred and sixty cases. Arch Intern Med 1946;78:629–661.CrossRefGoogle Scholar
  426. 426.
    Aguado JM, Obeso G, Cabanillas JJ, Fernandez-Guerrero M, Ales J. Pleuropulmonary infections due to nontyphoid strains of Salmonella. Arch Intern Med 1990;150:54–56.PubMedCrossRefGoogle Scholar
  427. 427.
    Berkeley D, Mangels J. Salmonella pneumonia in a patient with carcinoma of the lung. Am J Clin Pathol 1980;74:476–478.PubMedGoogle Scholar
  428. 428.
    Canney PA, Larsson SN, Hay JH, Yussuf MA. Salmonella pneumonia associated with chemotherapy for non-Hodgkin’s lymphoma. Clin Radiol 1985;36:459–460.PubMedCrossRefGoogle Scholar
  429. 429.
    Finegold MJ. Pneumonic plague in monkeys. An electron microscopic study. Am J Pathol 1969;54:167–185.PubMedGoogle Scholar
  430. 430.
    Cavanaugh DC, Randall R. The role of multiplication of Pasteurella pestis in mononuclear phagocytes. J Immunol 1959;83:348–363.PubMedGoogle Scholar
  431. 431.
    Monte TC. Properties and pharmacological action of plague murine toxin. Pharmacol Ther 1981;12:491–499.CrossRefGoogle Scholar
  432. 432.
    Meyer KF. The ecology of plague. Medicine 1942;21:143–174.Google Scholar
  433. 433.
    World Health Organization Technical Report Series (No. 165). Expert committee on plague. Geneva: World Health Organization, 1959.Google Scholar
  434. 434.
    Morris JT, McAllister CK. Bubonic plague. South Med J 1992;85:326–327.PubMedCrossRefGoogle Scholar
  435. 435.
    Wu L-T, Woodhead GS. Notes on the histology of some of the lesions present in pneumonic plague. J Path Bact 1914;19:1–32.Google Scholar
  436. 436.
    Werner SB, Weidmer CE, Nelson BC, Nygaard GS, Goethals RM, Poland JD. Primary plague pneumonia contracted from a domestic cat at South Lake Tahoe, Calif. JAMA 1984;251:929–931.PubMedCrossRefGoogle Scholar
  437. 437.
    CDC. Pneumonic plague—Arizona, 1992. MMWR Morb Mortal Wkly Rep 1992;41:737–739.Google Scholar
  438. 438.
    Burmeister RW, Tigertt WD, Overholt EL. Laboratory-acquired pneumonic plague. Report of a case and review of previous cases. Ann Intern Med 1962;56:789–800.PubMedCrossRefGoogle Scholar
  439. 439.
    Smith JH, Reisner BS. Plague. In: Connor DH, Chandler FW, Manz HJ, Schwartz DA, Lack EE, eds. Pathology of infectious diseases. Stamford: Appleton & Lange, 1997:729–738.Google Scholar
  440. 440.
    Ostroff SM, Kapperud G, Lassen J, Aasen S, Tauxe RV. Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis 1992;166:812–817.PubMedCrossRefGoogle Scholar
  441. 441.
    Bottone EJ. Yersinia enterocolitica: a panoramic view of a charismatic microorganism. Crit Rev Clin Lab Sci 1977;5:211–241.Google Scholar
  442. 442.
    Portnoy D, Martinez LA. Yersinia enterocolitica septicemia with pneumonia. Can Med Assoc J 1979;120:61–62.PubMedGoogle Scholar
  443. 443.
    Ettensohn DB, Roberts NJ, Jr. Yersinia enterocolitica pneumonia. N Y State J Med 1981;81:791–794.PubMedGoogle Scholar
  444. 444.
    Bigler RD, Atkins RR, Wing EJ. Yersinia enterocolitica lung infection. Arch Intern Med 1981;141:1529–1530.PubMedCrossRefGoogle Scholar
  445. 445.
    Taylor BG, Zafarzai MZ, Humphreys DW, Manfredi F. Nodular pulmonary infiltrates and septic arthritis associated with Yersinia enterocolitica bacteremia. Am Rev Respir Dis 1977;116:525–529.PubMedGoogle Scholar
  446. 446.
    Cropp AJ, Gaylord SF, Watanakunakorn C. Cavitary pneumonia due to Yersinia enterocolitica in a healthy man. Am J Med Sci 1984;288:130–132.PubMedCrossRefGoogle Scholar
  447. 447.
    Sebes JI, Mabry EH Jr, Rabinowitz JG. Lung abscess and osteomyelitis of rib due to Yersinia enterocolitica. Chest 1976;69:546–548.PubMedCrossRefGoogle Scholar
  448. 448.
    Kane DR, Reuman DD. Yersinia enterocolitica causing pneumonia and empyema in a child and a review of the literature. Pediatr Infect Dis J 1992;11:591–593.PubMedCrossRefGoogle Scholar
  449. 449.
    Bae BH, Sureka SB, Ajamy JA. Enteric group 15 (Enterobacteriaceae) associated with pneumonia. J Clin Microbiol 1981;14:596–597.PubMedGoogle Scholar
  450. 450.
    Pfeiffer R. Vorläufige Mitteilungen über die Erreger der Influenza. Dtsch Med Wochenschr 1892;18:28.CrossRefGoogle Scholar
  451. 451.
    Musher DM, Kubitschek KR, Crennan J, Baughn RE. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983;99:444–450.PubMedCrossRefGoogle Scholar
  452. 452.
    Pittman M. Variation and type specificity in the bacterial species Hemophilus influenzae. J Exp Med 1931;53:471.PubMedCrossRefGoogle Scholar
  453. 453.
    Smith W, Andrews CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 1933;2:66.CrossRefGoogle Scholar
  454. 454.
    Takala AK, Meurman O, Kleemola M, et al. Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. Pediatr Infect Dis J 1993;12:189–195.PubMedCrossRefGoogle Scholar
  455. 455.
    Ginsburg CM, Howard JB, Nelson JD. Report of 65 cases of Haemophilus influenzae b pneumonia. Pediatrics 1979;64(3):283–286.PubMedGoogle Scholar
  456. 456.
    Levin DC, Schwarz MI, Matthay RA, LaForce FM. Bacteremic Hemophilus influenzae pneumonia in adults. A report of 24 cases and a review of the literature. Am J Med 1977;62:219–224.PubMedCrossRefGoogle Scholar
  457. 457.
    Alsever RN, Stiver HG, Dinerman N, Dahl CR, Eickhoff TC. Haemophilus influenzae pericarditis and empyema with thyroiditis in an adult. JAMA 1974;230:1426–1427.PubMedCrossRefGoogle Scholar
  458. 458.
    Wallace RJ Jr, Musher DM, Martin RR. Hemophilus influenzae pneumonia in adults. Am J Med 1978;64:87–93.PubMedCrossRefGoogle Scholar
  459. 459.
    Kaplan NM, Braude AI. Hemophilus influenzae infection in adults. Arch Intern Med 1958;101:515.CrossRefGoogle Scholar
  460. 460.
    Warner JO, Gordon I. Pneumatocoeles following Haemophilus influenzae pneumonia. Clin Radiol 1981;32(1):99–105.PubMedCrossRefGoogle Scholar
  461. 461.
    Moxon ER, Wilson R. The role of Haemophilus influenzae in the pathogenesis of pneumonia. Rev Infect Dis 1991;13:S518–S527.PubMedCrossRefGoogle Scholar
  462. 462.
    Jacobs NM, Harris VJ. Acute Haemophilus pneumonia in childhood. Am J Dis Child 1979;133:603–605.PubMedGoogle Scholar
  463. 463.
    Asmar BI, Slovis TL, Reed JO, Dajani AS. Hemophilus influenzae type B pneumonia in 43 children. J Pediatr 1978;93(3):389–393.PubMedCrossRefGoogle Scholar
  464. 464.
    Keefer CS, Rammelkamp CH. Hemophilus influenzae bacteremia: report of two cases recovering following sulfathiazole and sulfapyridine. Ann Intern Med 1942;16:1221–1227.CrossRefGoogle Scholar
  465. 465.
    Everett ED, Rham AE Jr, Adaniya R, Stevens DL, McNitt TR. Haemophilus influenzae pneumonia in adults. JAMA 1977;238:319–321.PubMedCrossRefGoogle Scholar
  466. 466.
    Buttery J, Moxon ER. Capsulate bacteria and the lung. Br Med Bull 2002;61:63–80.PubMedCrossRefGoogle Scholar
  467. 467.
    Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22–25, 2002. J Pediatr 2003;143(6 suppl):S163–S187.PubMedGoogle Scholar
  468. 468.
    Quintiliani R, Hymans PJ. The association of bacteremic Haemophilus influenzae pneumonia in adults with typable strains. Am J Med 1971;50:781–786.PubMedCrossRefGoogle Scholar
  469. 469.
    Lowe MB. Haemophilus influenzae type c bronchopneumonia. J Path Bact 1964;88:315.PubMedCrossRefGoogle Scholar
  470. 470.
    Holmes RL, Kozinn WP. Pneumonia and bacteremia associated with Haemophilus influenzae serotype d. J Clin Microbiol 1983;18:730–732.PubMedGoogle Scholar
  471. 471.
    Dworzack DL, Blessing LD, Hodges GR, Barnes WG. Hemophilus influenzae type F pneumonia in adults. Am J Med Sci 1978;275:87–91.PubMedCrossRefGoogle Scholar
  472. 472.
    Eskola J, Peltola H, Takala AK, et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med 1987;317(12):717–722.PubMedCrossRefGoogle Scholar
  473. 473.
    Kristensen K. Haemophilus influenzae type b. Epidemiology of invasive diseases, antimicrobial resistance of clinical isolates, and response to a conjugate vaccine in selected risk groups. Dan Med Bull 1999;46(4):303–312.PubMedGoogle Scholar
  474. 474.
    Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13(2):302–317.PubMedCrossRefGoogle Scholar
  475. 475.
    Claesson BA, Lagergärd T, Trollfors B. Antibody response to outer membrane of noncapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia. Pediatr Infect Dis J 1991;10:104–108.PubMedCrossRefGoogle Scholar
  476. 476.
    Liston TE, Foshee WS. Invasive disease due to nontypable Haemophilus influenzae in children. South Med J 1982;75:753–754.PubMedCrossRefGoogle Scholar
  477. 477.
    Shann F. Haemophilus influenzae pneumonia: type b or non-type b? Lancet 1999;354(9189):1488–1490.PubMedCrossRefGoogle Scholar
  478. 478.
    Klein JO. Role of nontypeable Haemophilus influenzae in pediatric respiratory tract infections. Pediatr Infect Dis J 1997;16(2 suppl):S5–S8.PubMedGoogle Scholar
  479. 479.
    Berk SL, Holtsclaw SA, Wiener SL, Smith JK. Nontypeable Haemophilus influenzae in the elderly. Arch Intern Med 1982;142:537–539.PubMedCrossRefGoogle Scholar
  480. 480.
    Miller EH Jr, Caplan ES. Nosocomial Hemophilus pneumonia in patients with severe trauma. Surg Gynecol Obstet 1984;159:153–156.PubMedGoogle Scholar
  481. 481.
    Pearlberg J, Haggar AM, Saravolatz L, Beute GH, Popovich J. Hemophilus influenzae pneumonia in the adult. Radiographic appearance with clinical correlation. Radiology 1984;151:23–26.PubMedGoogle Scholar
  482. 482.
    Tillotson JR, Lerner AM. Hemophilus influenzae bronchopneumonia in adults. Arch Intern Med 1968;121(5):428–432.PubMedCrossRefGoogle Scholar
  483. 483.
    Henry SA, Gold JW, Freiman AH, Armstrong D. Chronic pneumonitis caused by Hemophilus influenzae in an adult. Arch Intern Med 1983;143:1461–1462.PubMedCrossRefGoogle Scholar
  484. 484.
    Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992;14(5):1119–1123.PubMedCrossRefGoogle Scholar
  485. 485.
    Klugman KP. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother 1996;38(suppl A):133–140.PubMedCrossRefGoogle Scholar
  486. 486.
    Johnson WD, Kaye D, Hook EW. Hemophilus influenzae pneumonia in adults. Am Rev Respir Dis 1968;97:1112–1117.PubMedGoogle Scholar
  487. 487.
    Pillai A, Mitchell JL, Hill SL, Stockley RA. A case of Haemophilus parainfluenzae pneumonia. Thorax 2000;55(7):623–624.PubMedCrossRefGoogle Scholar
  488. 488.
    Cooney TG, Harwood BR, Meisner DJ. Haemophilus parainfluenzae thoracic empyema. Arch Intern Med 1981;141:940–941.PubMedCrossRefGoogle Scholar
  489. 489.
    Arneborn P, Lindquist BL, Sjöberg L. Severe pulmonary infection by Haemophilus aphrophilus in a noncompromised child. Scand J Infect Dis 1985;17:327–329.PubMedGoogle Scholar
  490. 490.
    McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR. Legionnaires’ disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977;297:1197–1203.PubMedCrossRefGoogle Scholar
  491. 491.
    Reingold AL, Thomason BM, Brake BJ, Thacker L, Wilkinson HW, Kuritsky JN. Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness. J Infect Dis 1984;149:819.PubMedCrossRefGoogle Scholar
  492. 492.
    Glick TH, Gregg MB, Berman B, Mallison G, Rhodes WW Jr, Kassanoff I. Pontiac fever. An epidemic of unknown etiology in a health department: I. Clinical and epidemiologic aspects. Am J Epidemiol 1978;107:149–160.PubMedGoogle Scholar
  493. 493.
    Herwaldt LA, Gorman GW, McGrath T, et al. A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant. Ann Intern Med 1984;100:333–338.PubMedCrossRefGoogle Scholar
  494. 494.
    Knudsen F, Nielsen AH, Hansen KB. Legionella micdadei (Pittsburgh pneumonia agent) may cause non-pneumonic legionellosis. Lancet 1983;1:708.PubMedCrossRefGoogle Scholar
  495. 495.
    Goldberg DJ, Wrench JG, Collier PW, et al. Lochgoilhead fever: outbreak of non-pneumonic legionellosis due to Legionella micdadei. Lancet 1989;1:316–318.PubMedCrossRefGoogle Scholar
  496. 496.
    Fenstersheib MD, Miller M, Diggins C, et al. Outbreak of Pontiac fever due to Legionella anisa. Lancet 1990;336:35–37.PubMedCrossRefGoogle Scholar
  497. 497.
    Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires’ disease: description of an epidemic of pneumonia. N Engl J Med 1977;297:1189–1197.PubMedCrossRefGoogle Scholar
  498. 498.
    Shope RE. The infection of ferrets with swine influenza virus. J Exp Med 1934;60:49–61.PubMedCrossRefGoogle Scholar
  499. 499.
    Rogers BH, Donowitz GR, Walker GK, Harding SA, Sande MA. Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med 1979;301:959–961.PubMedCrossRefGoogle Scholar
  500. 500.
    Myerowitz RL, Pasculle AW, Dowling JN, et al. Opportunistic lung infection due to “Pittsburgh Pneumonia Agent.” N Engl J Med 1979;301:953–958.PubMedCrossRefGoogle Scholar
  501. 501.
    Gress FM, Myerowitz RL. The ultrastructural morphologic features of Pittsburgh pneumonia agent. Am J Pathol 1980;101:63–78.PubMedGoogle Scholar
  502. 502.
    Blackmon JA, Hicklin MD, Chandler FW Legionnaires’ disease. Pathological and historical aspects of a ‘new’ disease. Arch Pathol Lab Med 1978;102:337–343.PubMedGoogle Scholar
  503. 503.
    Hernandez FJ, Kirby BD, Stanley TM, Edelstein PH. Legionnaires’ disease. Postmortem pathologic findings of 20 cases. Am J Clin Pathol 1980;73(4):488–495.PubMedGoogle Scholar
  504. 504.
    Boyd JF, Buchanan WM, MacLeod TI, Dunn RI, Weir WP. Pathology of five Scottish deaths from pneumonic illnesses acquired in Spain due to Legionnaires’ disease agent. J Clin Pathol 1978;31:809–816.PubMedCrossRefGoogle Scholar
  505. 505.
    Carter JB, Wolter RK, Angres G, Saltzman P. Nodular Legionnaire’s disease. AJR 1981;137:612–613.PubMedCrossRefGoogle Scholar
  506. 506.
    Muder RR, Yu VL, Parry MF. The radiologic manifestations of Legionella pneumonia. Semin Respir Infect 1987;2:242–254.PubMedGoogle Scholar
  507. 507.
    Wade JS, Griffin FM Jr. Multinodular pneumonia caused by Legionella. Am J Med 1987;83:603.PubMedCrossRefGoogle Scholar
  508. 508.
    Pope TLJ, Armstrong P, Thompson R, Donowitz GR. Pittsburgh pneumonia agent: chest film manifestations. AJR 1982;138:237–241.PubMedCrossRefGoogle Scholar
  509. 509.
    Venkatachalam KK, Saravolatz LD, Christopher KL. Legionnaires’ disease. A cause of lung abscess. JAMA 1979;241:597–598.PubMedCrossRefGoogle Scholar
  510. 510.
    Lake KB, van Dyke JJ, Gerberg E, Browne PM. Legionnaires’ disease and pulmonary cavitation. Arch Intern Med 1979;139:485–486.PubMedCrossRefGoogle Scholar
  511. 511.
    Edwards D, Finlayson DM. Legionnaires’ disease causing severe lung abscesses. Can Med Assoc J 1980;123:524–527.PubMedGoogle Scholar
  512. 512.
    Gibney RT, Herbert FA, King EG, Elliot JF. Prolonged cavitating pneumonia in a patient with serologic evidence of Legionnaires’ disease. Chest 1980;78:671–672.PubMedCrossRefGoogle Scholar
  513. 513.
    Magnussen CR, Israel RH. Legionnaires’ lung abscess. Am J Med Sci 1980;279:117–120.PubMedCrossRefGoogle Scholar
  514. 514.
    Fairbank JT, Mamourian AC, Dietrich PA, Girod JC. The chest radiograph in Legionnaires’ disease. Further observations. Radiology 1983;147:33–34.PubMedGoogle Scholar
  515. 515.
    Randolph KA, Beekman JF. Legionnaires’ disease presenting with empyema. Chest 1979;75:404–406.PubMedCrossRefGoogle Scholar
  516. 516.
    Halberstam M, Isenberg HD, Hilton E. Abscess and empyema caused by Legionella micdadei. J Clin Microbiol 1992;30:512–513.PubMedGoogle Scholar
  517. 517.
    Strampfer MJ, Schoch PE, Scoma S, Cunha BA. Empyema and Legionella bozemanii. Ann Intern Med 1986;105:626.PubMedCrossRefGoogle Scholar
  518. 518.
    Brettman LR, DeHertogh D, Rank EL, Mandour MA. Legionella bozemanii and empyema. Ann Intern Med 1986;105:146–147.PubMedCrossRefGoogle Scholar
  519. 519.
    Weisenburger DD, Helms CM, Renner ED. Sporadic Legionnaires’ disease. A pathologic study of 23 fatal cases. Arch Pathol Lab Med 1981;105:130–137.PubMedGoogle Scholar
  520. 520.
    Leder LD. Uber die selektive fermentcytochemische Darstellung von neutrophilen myeloischen Zellen und Gewabsmastzellen im Paraffinschnitt. Klin Wochenschr 1964;42:553.PubMedCrossRefGoogle Scholar
  521. 521.
    Chandler FW, Cole RM, Hicklin MD, Blackmon JA, Callaway CS. Ultrastructure of the legionnaires’ disease bacterium. A study using transmission electron microscopy. Ann Intern Med 1979;90:642–647.PubMedCrossRefGoogle Scholar
  522. 522.
    Glavin FL, Winn WC Jr, Craighead JE. Ultrastructure of lung in legionnaires’ disease. Observations of three biopsies done during the Vermont epidemic. Ann Intern Med 1979;90:555–559.PubMedCrossRefGoogle Scholar
  523. 523.
    Horwitz MA, Silverstein SC. Legionnaires’ disease bacterium (Legionella pneumophila) multiplies intracellularly in human monocytes. J Clin Invest 1980;66:441–450.PubMedCrossRefGoogle Scholar
  524. 524.
    Silverman DJ, Wisseman CC Jr, Waddell AD, Jones M. External slime layers of Rickettsia prowazekii and Rickettsia rickettsii: occurrence of a slime layer. Infect Immun 1978;22:233–246.PubMedGoogle Scholar
  525. 525.
    Edelstein PH, Beer KB, Sturge JC, Watson AJ, Goldstein LC. Clinical utility of a monoclonal direct fluorescent reagent specific for Legionella pneumophila: comparative study with other reagents. J Clin Microbiol 1985;22:419–421.PubMedGoogle Scholar
  526. 526.
    Tenover FC, Edelstein PH, Goldstein LC, Sturge JC, Plorde JJ. Comparison of cross-staining reactions by Pseudomonas spp. and fluorescein-labeled polyclonal and monoclonal antibodies directed against Legionella pneumophila. J Clin Microbiol 1986;23:647–649.PubMedGoogle Scholar
  527. 527.
    Flournoy DJ, Belobraydic KA, Silberg SL, Lawrence CH, Guthrie PJ. False positive Legionella pneumophila direct immunofluorescent monoclonal antibody test caused by Bacillus cereus spores. Diagn Microbiol Infect Dis 1988;9:123–125.PubMedCrossRefGoogle Scholar
  528. 528.
    Benson RF, Thacker WL, Plikaytis BB, Wilkinson HW. Cross-reactions in Legionella antisera with Bordetella pertussis strains. J Clin Microbiol 1987;25:594–596.PubMedGoogle Scholar
  529. 529.
    Edelstein PH, Edelstein MA. Evaluation of the Merifluor-Legionella immunofluorescent reagent for identifying and detecting 21 Legionella species. J Clin Microbiol 1989;27:2455–2458.PubMedGoogle Scholar
  530. 530.
    Chandler FW, Hicklin MD, Blackmon JA. Demonstration of the agent of Legionnaires’ disease in tissue. N Engl J Med 1977;297:1218–1220.PubMedCrossRefGoogle Scholar
  531. 531.
    van Orden AE, Greer PW. Modification of the Dieterle spirochete stain. Histotechnology 1977;1:51–53.CrossRefGoogle Scholar
  532. 532.
    Elias JM, Greene C. Modified Steiner method for the demonstration of spirochetes in tissue. Am J Clin Pathol 1979;71:109–111.PubMedGoogle Scholar
  533. 533.
    Pounder DJ. Warthin-Starry for Legionella. Am J Clin Pathol 1983;80:276.PubMedGoogle Scholar
  534. 534.
    Frenkel JK, Baker LH, Chonko AM. Autopsy diagnosis of legionnaires’ disease in immunosuppressed patients. A paleodiagnosis using Giemsa stain (Wohlbach modification). Ann Intern Med 1979;90:559–562.PubMedCrossRefGoogle Scholar
  535. 535.
    Greer PW, Chandler FW, Hicklin MD. Rapid demonstration of Legionella pneumophila in unembedded tissue. An adaptation of the Gimenez stain. Am J Clin Pathol 1980;73:788–790.PubMedGoogle Scholar
  536. 536.
    Edelstein PH, Meyer RD, Finegold SM. Long-term followup of two patients with pulmonary cavitation caused by Legionella pneumophila. Am Rev Respir Dis 1981;124:90–93.PubMedGoogle Scholar
  537. 537.
    Case records of the Massachusetts General Hospital. Case 32-1978. N Engl J Med 1978;299:347–354.Google Scholar
  538. 538.
    Kariman K, Shelburne JD, Gough W, Zacheck MJ, Blackmon JA. Pathologic findings and long-term sequelae in Legionnaires’ disease. Chest 1979;75:736–739.PubMedCrossRefGoogle Scholar
  539. 539.
    Blackmon JA, Harley RA, Hicklin MD, Chandler FW. Pulmonary sequelae of acute legionnaires’ disease pneumonia. Ann Intern Med 1979;90:552–554.PubMedCrossRefGoogle Scholar
  540. 540.
    Chastre J, Raghu G, Soler P, Brun P, Basset F, Gibert C. Pulmonary fibrosis following pneumonia due to acute Legionnaires’ disease. Clinical, ultrastructural, and immunofluorescent study. Chest 1987;91:57–62.PubMedCrossRefGoogle Scholar
  541. 541.
    Fraser DW, Wachsmuth I, Bopp C, Feeley JC, Tsai TF. Antibiotic treatment of guinea-pigs infected with agent of Legionnaires’ disease. Lancet 1978;1:175–178.PubMedCrossRefGoogle Scholar
  542. 542.
    Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1983;5:279–313.PubMedCrossRefGoogle Scholar
  543. 543.
    Hoogwerf BJ, Khan MY. Community-acquired bacteremic Pseudomonas pneumonia in a health adult. Am Rev Respir Dis 1981;123:132–134.PubMedGoogle Scholar
  544. 544.
    Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 1985;145:1621–1629.PubMedCrossRefGoogle Scholar
  545. 545.
    Iannini PB, Claffey T, Quintiliani R. Bacteremic Pseudomonas pneumonia. JAMA 1974;230:558–561.PubMedCrossRefGoogle Scholar
  546. 546.
    Polsky B, Gold JW, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:38–41.PubMedCrossRefGoogle Scholar
  547. 547.
    Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997;25(3):551–573.PubMedCrossRefGoogle Scholar
  548. 548.
    Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000;19(12):915–925.PubMedCrossRefGoogle Scholar
  549. 549.
    Tillotson JR, Lerner AM. Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med 1968;68:295–307.PubMedCrossRefGoogle Scholar
  550. 550.
    Rose HD, Heckman MG, Unger JD. Pseudomonas aeruginosa pneumonia in adults. Am Rev Respir Dis 1973;107:416–422.PubMedGoogle Scholar
  551. 551.
    Watanakunakorn C. Vertebral osteomyelitis as a complication of Pseudomonas aeruginosa pneumonia. South Med J 1975;68:173–176.PubMedCrossRefGoogle Scholar
  552. 552.
    Quirk JA, Beaman MH, Blake M. Community-acquired Pseudomonas pneumonia in a normal host complicated by metastatic panophthalmitis and cutaneous pustules. Aust NZ J Med 1990;20(3):254–256.CrossRefGoogle Scholar
  553. 553.
    Mungall IP, Jackson EW, Dibble JB. Pseudomonas pneumonia in status asthmaticus. Postgrad Med J 1977;53(626):764–765.PubMedCrossRefGoogle Scholar
  554. 554.
    Crnich CJ, Gordon B, Andes D. Hot tub-associated necrotizing pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 2003;36(3):e55–e57.PubMedCrossRefGoogle Scholar
  555. 555.
    Fishman H, Eaton B, Lipson A, Delaney MD. Primary Pseudomonas pneumonia in a previously healthy man. South Med J 1983;76:260–262.PubMedCrossRefGoogle Scholar
  556. 556.
    Govan J, Reiss-Levy E, Bader L, Schonell M. Pseudomonas pneumonia with bacteraemia. Med J Aust 1977;1:627–628.PubMedGoogle Scholar
  557. 557.
    Siebert WT, Williams TW, Jr. Primary Pseudomonas pneumonia. South Med J 1980;73:75–77.PubMedCrossRefGoogle Scholar
  558. 558.
    Hatchette TF, Gupta R, Marrie TJ. Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis 2000;31(6):1349–1356.PubMedCrossRefGoogle Scholar
  559. 559.
    Case Records of the Massachusetts General Hospital. Case 15–1966. N Engl J Med 1966;274:736–744.CrossRefGoogle Scholar
  560. 560.
    Soave R, Murray HW, Litrenta MM. Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am J Med 1978;65:864–867.PubMedCrossRefGoogle Scholar
  561. 561.
    Kumar PD, Ravakhah K, West BC. Disseminated Pseudomonas aeruginosa and necrotizing pneumonia with complete recovery. South Med J 2001;94(2):229–232.PubMedGoogle Scholar
  562. 562.
    Uppington J, Penney MD. Unilateral pulmonary oedema and Pseudomonas pneumonia. Postgrad Med J 1980;56:677–678.PubMedCrossRefGoogle Scholar
  563. 563.
    Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989;95(1):155–161.PubMedCrossRefGoogle Scholar
  564. 564.
    Talon D, Mulin B, Rouget C, Bailly P, Thouverez M, Viel JF. Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. Am J Respir Crit Care Med 1998;157(3 pt 1):978–984.PubMedCrossRefGoogle Scholar
  565. 565.
    de Latorre FJ, Pont T, Ferrer A, Rossello J, Palomar M, Planas M. Pattern of tracheal colonization during mechanical ventilation. Am J Respir Crit Care Med 1995;152(3):1028–1033.PubMedCrossRefGoogle Scholar
  566. 566.
    Teplitz C. Pathogenesis of Pseudomonas vasculitis and septic lesions. Arch Pathol 1965;80:297–307.PubMedGoogle Scholar
  567. 567.
    Bonifacio SL, Kitterman JA, Ursell PC. Pseudomonas pneumonia in infants: an autopsy study. Hum Pathol 2003;34(9):929–938.PubMedCrossRefGoogle Scholar
  568. 568.
    Hart CA, Winstanley C. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull 2002;61:81–96.PubMedCrossRefGoogle Scholar
  569. 569.
    Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32(4):277–287.PubMedCrossRefGoogle Scholar
  570. 570.
    Costerton JW Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001;9(2):50–52.PubMedCrossRefGoogle Scholar
  571. 571.
    Rivera M, Nicotra MB. Pseudomonas aeruginosa mucoid strain. Its significance in adult chest diseases. Am Rev Respir Dis 1982;126:833–836.PubMedGoogle Scholar
  572. 572.
    Govan JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996;45(6):395–407.PubMedCrossRefGoogle Scholar
  573. 573.
    Jones AM, Dodd ME, Webb AK. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 2001;17(2):295–301.PubMedCrossRefGoogle Scholar
  574. 574.
    Tomashefski JF, Thomassen MJ, Bruce MC, et al. Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Relation of clinical features to histopathologic patterns of pneumonia. Arch Pathol Lab Med 1988;112:166–172.PubMedGoogle Scholar
  575. 575.
    Sajjan U, Corey M, Humar A, et al. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol 2001;50(6):535–546.PubMedGoogle Scholar
  576. 576.
    Potts SB, Roggli VL, Spock A. Immunohistologic quantification of Pseudomonas aeruginosa in the tracheobronchial tree from patients with cystic fibrosis. Pediatr Pathol Lab Med 1995;15(5):707–721.PubMedCrossRefGoogle Scholar
  577. 577.
    Baltimore RS, Christie CD, Smith GJ. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989;140(6):1650–1661.PubMedCrossRefGoogle Scholar
  578. 578.
    Belchis DA, Simpson E, Colby T. Histopathologic features of Burkholderia cepacia pneumonia in patients without cystic fibrosis. Mod Pathol 2000;13(4):369–372.PubMedCrossRefGoogle Scholar
  579. 579.
    Pujol M, Corbella X, Carratala J, Gudiol F. Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host. Clin Infect Dis 1992;15(5):887–888.PubMedCrossRefGoogle Scholar
  580. 580.
    Dailey RH, Benner EJ. Necrotizing pneumonitis due to the pseudomonad “Eugonic Oxidizer—Group I. N Engl J Med 1968;279:361–362.PubMedCrossRefGoogle Scholar
  581. 581.
    Whitmore A, Krishnaswami CS. An account of the discovery of a hitherto undescribed infective disease occurring among the population of Rangoon. Indian Med Gaz 1912;47:262.Google Scholar
  582. 582.
    Pollack M. Pseudomonas species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. New York: Churchill Livingstone, 2000:2310–2335.Google Scholar
  583. 583.
    Clayton AJ, Lisella RS, Martin DG. Melioidosis: a serological survey in military personnel. Mil Med 1973;138:24.PubMedGoogle Scholar
  584. 584.
    Finkelstein RA, Atthasampunna P, Chulasamaya M. Pseudomonas (Burkholderia) pseudomallei in Thailand, 1964–1967: geographic distribution of the organism, attempts to identify cases of active infection, and presence of antibody in representative sera. Am J Trop Med Hyg 2000;62(2):232–239.PubMedGoogle Scholar
  585. 585.
    Weber DR, Douglass LE, Brundage WG, Stallkamp TC. Acute varieties of melioidosis occurring in U.S. soldiers in Vietnam. Am J Med 1969;46:234–244.PubMedCrossRefGoogle Scholar
  586. 586.
    Mackowiak PA, Smith JW. Septicemic melioidosis—occurrence following acute influenza a six years after exposure in Vietnam. JAMA 1978;240(8):764–766.PubMedCrossRefGoogle Scholar
  587. 587.
    McCormick JB, Sexton DJ, McMuray JG, Carey E, Hayes P, Feldman RA. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med 1973;83:512–513.CrossRefGoogle Scholar
  588. 588.
    Greenwald KA, Nash G, Foley FD. Acute systemic melioidosis: autopsy findings in four patients. Am J Clin Pathol 1969;52:188–198.Google Scholar
  589. 589.
    Piggott JA, Hochholzer L. Human melioidosis. A histopathologic study of acute and chronic melioidosis. Arch Pathol 1970;90:101–111.PubMedGoogle Scholar
  590. 590.
    James AE, Dixon GD, Johnson HG. Melioidosis: A correlation of the radiologic and pathologic findings. Radiology 1967;89:230–235.Google Scholar
  591. 591.
    Everett ED, Nelson RA. Pulmonary melioidosis—observations in thirty-nine cases. Am Rev Respir Dis 1975;112:331–340.PubMedGoogle Scholar
  592. 592.
    Girard DE, Nardone DA, Jones SR. Pleural melioidosis. Am Rev Respir Dis 1976;114:1175–1178.PubMedGoogle Scholar
  593. 593.
    Buchman RJ, Kmiecik JE, LaNoue AM. Extrapulmonary melioidosis. Am J Surg 1973;125:324–327.PubMedCrossRefGoogle Scholar
  594. 594.
    Saengnipanthkul S, Laupattarakasem W, Kowsuwon W, Mahaisavariya B. Isolated articular melioidosis. Clin Orthop 1991;267:182–185.PubMedGoogle Scholar
  595. 595.
    Jackson AE, Moore WL Jr, Sandford JP. Recrudescent melioidosis associated with diabetic ketoacidosis. Arch Intern Med 1972;130:268–271.PubMedCrossRefGoogle Scholar
  596. 596.
    Baumann BB, Morita ET. Systemic melioidosis presenting as myocardial infarct. Ann Intern Med 1967;67(4):836–842.PubMedCrossRefGoogle Scholar
  597. 597.
    Wong KT, Puthucheary SD, Vadivelu J. The histopathology of human melioidosis. Histopathology 1995;26(1):51–55.PubMedCrossRefGoogle Scholar
  598. 598.
    Kunakorn M, Petchclai B, Khupulsup K, Naigowit P. Gold blot for detection of immunoglobulin M (IgM)-and IgG-specific antibodies for rapid serodiagnosis of meloidosis. J Clin Microbiol 1991;29:2065–2067.PubMedGoogle Scholar
  599. 599.
    Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968;44:599–605.PubMedCrossRefGoogle Scholar
  600. 600.
    Rosenthal SL, Zuger JH, Apollo E. Respiratory colonization with Pseudomonas putrefaciens after near-drowning in salt water. Am J Clin Pathol 1975;64:382–384.PubMedGoogle Scholar
  601. 601.
    Campos-Herrero MI, Bordes A, Rodriguez H, Perera A, Gonzalez B, Conde A. Pseudomonas stutzeri community-acquired pneumonia associated with empyema: case report and review. Clin Infect Dis 1997;25(2):325–326.PubMedCrossRefGoogle Scholar
  602. 602.
    Sarkar TK, Gilardi G, Aguam AS, Josephson J, Leventhal GL. Primary Pseudomonas maltophilia infection of the lung. Postgrad Med 1979;65:253–6, 260.PubMedGoogle Scholar
  603. 603.
    Zuravleff JJ, Yu VL. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis 1982;4:1236–1246.PubMedCrossRefGoogle Scholar
  604. 604.
    Khardori N, Elting L, Wong E, Schable B, Bodey GR Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990;12:997–1003.PubMedCrossRefGoogle Scholar
  605. 605.
    Tsiodras S, Pittet D, Carmeli Y, Eliopoulos G, Boucher H, Harbarth S. Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis 2000;32(6):651–656.PubMedCrossRefGoogle Scholar
  606. 606.
    Goss CH, Otto K, Aitken ML, Rubenfeld GD. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am J Respir Crit Care Med 2002;166(3):356–361.PubMedCrossRefGoogle Scholar
  607. 607.
    Trotter JA, Kuhls TL, Pickett DA, Reyes de la Rocha S, Welch DF. Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease. J Clin Microbiol 1990;28:1120–1124.PubMedGoogle Scholar
  608. 608.
    Patterson TF, Patterson JE, Masecar BL, Barden GE, Hierholzer WJ Jr, Zervos MJ. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988;157:996–1001.PubMedCrossRefGoogle Scholar
  609. 609.
    Wood GM, Johnson BC, McCormack JG. Moraxella catarrhalis: pathogenic significance in respiratory tract infections treated by community practitioners. Clin Infect Dis 1996;22(4):632–636.PubMedCrossRefGoogle Scholar
  610. 610.
    Thorsson B, Haraldsdottir V, Kristjansson M. Moraxella catarrhalis bacteraemia. A report on 3 cases and a review of the literature. Scand J Infect Dis 1998;30(2):105–109.PubMedCrossRefGoogle Scholar
  611. 611.
    Srinivasan G, Raff MJ, Templeton WC, Givens SJ, Graves RC, Melo JC. Branhamella catarrhalis pneumonia: report of two cases and review of the literature. Am Rev Respir Dis 1981;123:553–555.PubMedGoogle Scholar
  612. 612.
    Wright PW, Wallace RJ Jr, Shepherd JR. A descriptive study of 42 cases of Branhamella catarrhalis pneumonia. Am J Med 1990;88:2S–8S.PubMedCrossRefGoogle Scholar
  613. 613.
    Verduin CM, Hol C, Fleer A, van D H, van B A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev 2002;15(1):125–144.PubMedCrossRefGoogle Scholar
  614. 614.
    Ohlsson A, Bailey T. Neonatal pneumonia caused by Branhamella catarrhalis. Scand J Infect Dis 1985;17:225–228.PubMedGoogle Scholar
  615. 615.
    Keren G, Bogokowsky B, Barzilay Z. Branhamella catarrhalis pneumonia in non-immunocompromised pediatric patients: report of three cases and review of the literature. J Med 1989;20(1):65–72.PubMedGoogle Scholar
  616. 616.
    Malkamaki M, Honkanen E, Leinonen M, Makela PH. Branhamella catarrhalis as a cause of bacteremic pneumonia (case report). Scand J Infect Dis 1983;15:125–126.PubMedGoogle Scholar
  617. 617.
    Choo PW, Gantz NM. Branhamella catarrhalis pneumonia with bacteremia. South Med J 1989;82:1317–1318.PubMedCrossRefGoogle Scholar
  618. 618.
    Rosett W, Heck DM, Hodges GR. Pneumonitis and pulmonary abscess associated with Moraxella nonliquefaciens. Chest 1976;70:664–665.PubMedCrossRefGoogle Scholar
  619. 619.
    Goetz MB, Jones J. Pneumonia and bacteremia caused by a previously undescribed Moraxella-like bacterium. J Clin Microbiol 1982;15:720–722.PubMedGoogle Scholar
  620. 620.
    Abrahamsen TG, Finne PH, Lingaas E. Flavobacterium meningosepticum infections in a neonatal intensive care unit. Acta Paediatr Scand 1989;78:51–55.PubMedCrossRefGoogle Scholar
  621. 621.
    Uchihara T, Yokota T, Watabiki S, Ueki M, Miyake S, Tsukagoshi H. Flavobacterium meningosepticum meningitis in an adult. Am J Med 1988;85:738–739.PubMedCrossRefGoogle Scholar
  622. 621.
    Ashdown LR, Previtera S. Community acquired Flavobacterium meningosepticum pneumonia and septicaemia. Med J Aust 1992;156:69–70.PubMedGoogle Scholar
  623. 623.
    Sundin D, Gold BD, Berkowitz FE, Schwartz DA, Goo D. Community-acquired Flavobacterium meningosepticum meningitis, pneumonia and septicemia in a normal infant. Pediatr Infect Dis J 1991;10:73–76.PubMedGoogle Scholar
  624. 624.
    Tarn AY, Yung RW, Fu KH. Fatal pneumonia caused by Flavobacterium meningosepticum. Pediatr Infect Dis J 1989;8:252–254.Google Scholar
  625. 625.
    Teres D. ICU-acquired pneumonia due to Flavobacterium meningosepticum. JAMA 1974;228:732.PubMedCrossRefGoogle Scholar
  626. 626.
    Brown RB, Phillips D, Barker MJ, Pieczarka R, Sands M, Teres D. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B. Am J Infect Control 1989;17:121–125.PubMedCrossRefGoogle Scholar
  627. 627.
    Raimondi A, Moosdeen F, Williams JD. Antibiotic resistance pattern of Flavobacterium meningosepticum. Eur J Clin Microbiol 1986;5:461–463.PubMedCrossRefGoogle Scholar
  628. 628.
    Casalta JP, Peloux Y, Raoult D, Brunet P, Gallais H. Pneumonia and meningitis caused by a new nonfermentative unknown gram-negative bacterium. J Clin Microbiol 1989;27:1446–1448.PubMedGoogle Scholar
  629. 629.
    Reines HD, Cook FV. Pneumonia and bacteremia due to Aeromonas hydrophila. Chest 1981;80:264–267.PubMedCrossRefGoogle Scholar
  630. 630.
    Baddour LM, Baselski VS. Pneumonia due to Aeromonas hydrophila-complex: epidemiologic, clinical, and microbiologic features. South Med J 1988;81:461–463.PubMedCrossRefGoogle Scholar
  631. 631.
    Kelly MT, Avery DM. Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim. J Clin Microbiol 1980;11:278–280.PubMedGoogle Scholar
  632. 632.
    Janda JM, Powers C, Bryant RG, Abbott SL. Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev 1988;1(3):245–267.PubMedGoogle Scholar
  633. 633.
    Wallace RJ Jr, Awe RJ, Martin RR. Bacteremic Acinetobacter (Herellea) pneumonia with survival: case report. Am Rev Respir Dis 1976;113:695–699.PubMedGoogle Scholar
  634. 634.
    Gottlieb T, Barnes DJ. Community-acquired Acinetobacter pneumonia. Aust NZ J Med 1989;19:259–260.CrossRefGoogle Scholar
  635. 635.
    Goodhart GL, Abrutyn E, Watson R, Root RK, Egert J. Community-acquired Acinetobacter calcoaceticus var anitratus pneumonia. JAMA 1977;238:1516–1518.PubMedCrossRefGoogle Scholar
  636. 636.
    Cordes LG, Brink EW, Checko PJ, et al. A cluster of Acinetobacter pneumonia in foundry workers. Ann Intern Med 1981;95:688–693.PubMedCrossRefGoogle Scholar
  637. 637.
    Cunha BA, Klimek JJ, Gracewski J, McLaughlin JC, Quintiliani R. A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers. Postgrad Med J 1980;56:169–172.PubMedCrossRefGoogle Scholar
  638. 638.
    Milder JE, Hall NK, Finley RA. Pasteurella multocida pneumonia and bacteremia. South Med J 1977;70:1123–1124.PubMedCrossRefGoogle Scholar
  639. 639.
    Ruiz-Santana S, Antunez IA, Armas M, Rodriguez de Castro F, Manzano JL. Telescoping plugged catheter. An unusual way of diagnosing Pasteurella multocida pneumonia. Chest 1991;99:1517.PubMedCrossRefGoogle Scholar
  640. 640.
    Rose HD, Mathai G. Acute Pasteurella multocida pneumonia. Br J Dis Chest 1977;71:123–126.PubMedCrossRefGoogle Scholar
  641. 641.
    Schmidt EC, Truitt LV, Koch ML. Pulmonary abscess with empyema caused by Pasteurella multocida. Am J Clin Pathol 1970;54:733–736.PubMedGoogle Scholar
  642. 642.
    Maneche HC, Toll HW. Pulmonary cavitation and massive hemorrhage caused by Pasteurella multocida. N Engl J Med 1964;271:491–494.PubMedCrossRefGoogle Scholar
  643. 643.
    Olsen AM, Needham GM. Pasteurella multocida in suppurative diseases of the respiratory tract. Am J Med Sci 1952;224:77–81.PubMedCrossRefGoogle Scholar
  644. 644.
    Starkebaum GA, Plorde JJ. Pasteurella pneumonia: report of a case and review of the literature. J Clin Microbiol 1977;5:332–335.PubMedGoogle Scholar
  645. 645.
    Boyce JM. Recent trends in the epidemiology of tularemia in the United States. J Infect Dis 1975;131:197–199.PubMedCrossRefGoogle Scholar
  646. 646.
    Taylor JP, Istre GR, McChesney TC, et al. Epidemiologic characteristics of human tularemia in the southwest-central states, 1981–1987. Am J Epidemiol 1991;133:1032–1038.PubMedGoogle Scholar
  647. 647.
    Rohrbach BW, Westerman E, Istre GR. Epidemiology and clinical characteristics of tularemia in Oklahoma, 1979 to 1985. South Med J 1991;84:1091–1096.PubMedCrossRefGoogle Scholar
  648. 648.
    Martone WJ, Marshall LW, Kaufmann AF, Hobbs JH, Levy ME. Tularemia pneumonia in Washington, DC. A report of three cases with possible common-source exposures. JAMA 1979;242:2315–2317.PubMedCrossRefGoogle Scholar
  649. 649.
    Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev 2002;15(4):631–646.PubMedCrossRefGoogle Scholar
  650. 650.
    Pullen RL, Stuart BM. Tularemia analysis of 225 cases. JAMA 1945;129:495–500.CrossRefGoogle Scholar
  651. 651.
    Stuart BM, Pullen RL. Tularemic pneumonia. Review of American literature and report of 15 additional cases. Am J Med Sci 1945;210:223–236.CrossRefGoogle Scholar
  652. 652.
    Mille RP, Bates JH. Pleuropulmonary tularemia. A review of 29 patients. Am Rev Respir Dis 1969;99:31–41.Google Scholar
  653. 653.
    Avery FW, Barnett TB. Pulmonary tularemia. A report of five cases and consideration of pathogenesis and terminology. Am Rev Respir Dis 1967;95:584–591.PubMedGoogle Scholar
  654. 654.
    Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of primary pneumonic tularemia on Martha’s Vineyard. N Engl J Med 2001;345(22):1601–1606.PubMedCrossRefGoogle Scholar
  655. 655.
    Sunderrajan EV, Hutton J, Marienfeld RD. Adult respiratory distress syndrome secondary to tularemia pneumonia. Arch Intern Med 1985;145:1435–1437.PubMedCrossRefGoogle Scholar
  656. 656.
    Verbrycke JR. Tularemia. With report of fatal case simulating cholangeitis, with postmortem report. JAMA 1924;82:1577–1581.CrossRefGoogle Scholar
  657. 657.
    Permar HH, MacLachlan WWG. Tularemic pneumonia. Ann Intern Med 1931;5:687–698.CrossRefGoogle Scholar
  658. 658.
    Sato T, Fujita H, Ohara Y, Homma M. Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol 1990;28:2372–2374.PubMedGoogle Scholar
  659. 659.
    Grunow R, Splettstoesser W, McDonald S, et al. Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin Diagn Lab Immunol 2000;7(1):86–90.PubMedGoogle Scholar
  660. 660.
    Roy TM, Fleming D, Anderson WH. Tularemic pneumonia mimicking Legionnaires’ disease with false-positive direct fluorescent antibody stains for Legionella. South Med J 1989;82:1429–1431.PubMedCrossRefGoogle Scholar
  661. 661.
    Westerman EL, McDonald J. Tularemia pneumonia mimicking legionnaires’ disease: isolation of organism on CYE agar and successful treatment with erythromycin. South Med J 1983;76:1169–1170.PubMedCrossRefGoogle Scholar
  662. 662.
    Tularemia—Oklahoma, 2000. MMWR Morb Mortal Wkly Rep 2001;50(33):704–706.Google Scholar
  663. 663.
    Young EJ. Human brucellosis. Rev Infect Dis 1983;5:821–842.PubMedCrossRefGoogle Scholar
  664. 664.
    Joint FAO/WHO Expert Committee on Brucellosis. Geneva: World Health Organization, 1986.Google Scholar
  665. 665.
    Pfischner WCE, Tshak KG, Neptune EM. Brucellosis in Egypt. A review of experience with 228 patients. Am J Med 1957;22:915–929.PubMedCrossRefGoogle Scholar
  666. 666.
    Schirger A, Nichols DR, Martin WJ, Wellman WE, Weed LA. Brucellosis—experience with 224 patients. Ann Intern Med 1960;52:827–837.PubMedCrossRefGoogle Scholar
  667. 667.
    Buchanan TM, Faber LC, Feldman RA. Brucellosis in the United States 1960–1972. An abattoir-associated disease. Part 1. Clinical features and therapy. Medicine 1974;53:403–413.PubMedCrossRefGoogle Scholar
  668. 668.
    Blankenship RM, Sanford JP. Brucella canis: a cause of undulant fever. Am J Med 1975;59:424–426.PubMedCrossRefGoogle Scholar
  669. 669.
    Hunt AC, Bothwell PW. Histological findings in human brucellosis. J Clin Pathol 1967;20:267–272.PubMedCrossRefGoogle Scholar
  670. 670.
    Harvey WA. Pulmonary brucellosis. Ann Intern Med 1948;28:768–781.PubMedCrossRefGoogle Scholar
  671. 671.
    Agarwal S, Kadhi SK, Rooney RJ. Brucellosis complicating bilateral total knee arthroplasty. Clin Orthop 1991;267:179–181.PubMedGoogle Scholar
  672. 672.
    Haden RL, Kyger ER. Pulmonary manifestations of brucellosis. Cleve Clin Q 1946;13:220–227.PubMedGoogle Scholar
  673. 673.
    Greer AE. Pulmonary brucellosis. Dis Chest 1956;29:508–519.PubMedCrossRefGoogle Scholar
  674. 674.
    Walus MA, Young EJ. Concomitant neurocysticercosis and brucellosis. Am J Clin Pathol 1990;94(6):790–792.PubMedGoogle Scholar
  675. 675.
    Peery TM, Belter LF. Brucellosis and heart disease. II. Fatal brucellosis—a review of the literature and report of new cases. Am J Pathol 1960;36:673–697.PubMedGoogle Scholar
  676. 676.
    Weed LA, Sloss PT, Clagett OT. Chronic localized pulmonary brucellosis. JAMA 1956;161:1044–1047.CrossRefGoogle Scholar
  677. 677.
    Abu-Ekteish F, Kakish K. Pneumonia as the sole presentation of brucellosis. Respir Med 2001;95(9):766–767.PubMedCrossRefGoogle Scholar
  678. 678.
    Pappas G, Bosilkovski M, Akritidis N, Mastora M, Krteva L, Tsianos E. Brucellosis and the respiratory system. Clin Infect Dis 2003;37(7):e95–e99.PubMedCrossRefGoogle Scholar
  679. 679.
    Castaneda MR. Laboratory diagnosis of brucellosis in man. Bull WHO 1961;24:73–84.Google Scholar
  680. 680.
    Goldbaum FA, Rubbi CP, Wallach JC, et al. Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses. J Clin Microbiol 1992;30:604–607.PubMedGoogle Scholar
  681. 681.
    Hunter SB, Bibb WF, Shih CN, et al. Enzyme-linked immunosorbent assay with outer membrane proteins of Brucella melitensis to measure immune response to Brucella species. J Clin Microbiol 1986;24:566–572.PubMedGoogle Scholar
  682. 682.
    Morata P, Queipo-Ortuno MI, Reguera JM, Garcia-Ordonez MA, Cardenas A, Colmenero JD. Development and evaluation of a PCR-enzyme-linked immunosorbent assay for diagnosis of human brucellosis. J Clin Microbiol 2003;41(1):144–148.PubMedCrossRefGoogle Scholar
  683. 683.
    Geller RJ. The pertussis syndrome: a persistent problem. Pediatr Infect Dis 1984;3:182–186.PubMedCrossRefGoogle Scholar
  684. 684.
    Field LH, Parker CD. Pertussis outbreak in Austin and Travis County, Texas, 1975. J Clin Microbiol 1977;6:154–160.PubMedGoogle Scholar
  685. 685.
    Brooksaler F, Nelson JD. Pertussis. A reappraisal and report of 190 confirmed cases. Am J Dis Child 1967;114:389–396.PubMedGoogle Scholar
  686. 686.
    Granstrom M, Askelof P. Parapertussis: an abortive pertussis infection? Lancet 1982;2:1249–1250.PubMedCrossRefGoogle Scholar
  687. 687.
    Feldmann GV, Macaulay D, Abbott JD, Cradock Watson JE, Tobin JO. Viruses and whooping-cough. Lancet 1972;1:379.PubMedCrossRefGoogle Scholar
  688. 688.
    Nelson WL, Hopkins RS, Roe MH, Glode MP. Simultaneous infection with Bordetella pertussis and respiratory syncytial virus in hospitalized children. Pediatr Infect Dis 1986;5:540–544.PubMedCrossRefGoogle Scholar
  689. 689.
    MacLean DW. Adults with pertussis. J R Coll Gen Pract 1982;32:298–300.PubMedGoogle Scholar
  690. 690.
    Mertsola J, Ruuskanen O, Eerola E, Viljanen MK. Intrafamilial spread of pertussis. J Pediatr 1983;103:359–363.PubMedCrossRefGoogle Scholar
  691. 691.
    Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32(12):1691–1697.PubMedCrossRefGoogle Scholar
  692. 692.
    Ng VL, York M, Hadley WK. Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome. J Clin Microbiol 1989;27:337–338.PubMedGoogle Scholar
  693. 693.
    Sotomayor J, Weiner LB, McMillan JA. Inaccurate diagnosis in infants with pertussis. An eight-year experience. Am J Dis Child 1985;139:724–727.PubMedGoogle Scholar
  694. 694.
    Gilligan PH, Fisher MC. Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol 1984;20(5):891–893.PubMedGoogle Scholar
  695. 695.
    Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977;6:303–309.PubMedGoogle Scholar
  696. 696.
    Whitaker JA, Donaldson P, Nelson JD. Diagnosis of pertussis by the fluorescent-antibody method. N Engl J Med 1960;263:850–851.PubMedCrossRefGoogle Scholar
  697. 697.
    Donaldson P, Whitaker JA. Diagnosis of pertussis by fluorescent antibody staining of nasopharyngeal smears. Am J Dis Child 1960;99:423–427.Google Scholar
  698. 698.
    Broome CV, Fraser DW, English WJ, II. International Symposium on Pertussis. DHEW Publication No. (NIH)79-1830. Bethesda, MD: US. Department of Health, Education, and Welfare, 1978.Google Scholar
  699. 699.
    Hakansson S, Sundin CG, Granstrom M, Gastrin B. Diagnosis of whooping cough—a comparison of culture, immunofluorescence and serology with ELISA. Scand J Infect Dis 1984;16:281–284.PubMedCrossRefGoogle Scholar
  700. 700.
    Fry NK, Tzivra O, Li YT, et al. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol 2004;53 (pt 6):519–525.PubMedCrossRefGoogle Scholar
  701. 701.
    Hallander HO. Microbiological and serological diagnosis of pertussis. Clin Infect Dis 1999;28(suppl 2):S99–106.PubMedCrossRefGoogle Scholar
  702. 702.
    Duncan JR, Ross RF, Switzer WP, Ramsey FK. Pathology of experimental Bordetella bronchiseptica infection in swine: atrophic rhinitis. Am J Vet Res 1966;27(117):457–466.PubMedGoogle Scholar
  703. 703.
    Reina J, Bassa A, Llompart I, Borrell N, Gomez J, Serra A. Pneumonia caused by Bordetella bronchiseptica in a patient with a thoracic trauma. Infection 1991;19:46–48.PubMedCrossRefGoogle Scholar
  704. 704.
    Ner Z, Ross LA, Horn MV, et al. Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr Transplant 2003;7(5):413–417.PubMedCrossRefGoogle Scholar
  705. 705.
    Lorenzo-Pajuelo B, Villanueva JL, Rodriguez-Cuesta J, et al. Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens. J Clin Microbiol 2002;40(9):3146–3154.PubMedCrossRefGoogle Scholar
  706. 706.
    Gomez L, Grazziutti M, Sumoza D, Beran M, Rolston K. Bacterial pneumonia due to Bordetella bronchiseptica in a patient with acute leukemia. Clin Infect Dis 1998;26(4):1002–1003.PubMedCrossRefGoogle Scholar
  707. 707.
    Mandell WF, Garvey GJ, Neu HC. Achromobacter xylosoxidans bacteremia. Rev Infect Dis 1987;9:1001–1005.PubMedCrossRefGoogle Scholar
  708. 708.
    Dworzack DL, Murray CM, Hodges GR, Barnes WG. Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol 1978;70:712–717.PubMedGoogle Scholar
  709. 709.
    Goldstein EJ, Kirby BD, Finegold SM. Isolation of Eikenella corrodens from pulmonary infections. Am Rev Respir Dis 1979;119:55–58.PubMedGoogle Scholar
  710. 710.
    Brown JR. Human actinomycosis: a study of 181 subjects. Hum Pathol 1973;4:319–330.PubMedCrossRefGoogle Scholar
  711. 711.
    Causey WA. Actinomycosis. In: Handbook of clinical neurology, vol. 35. Infections of the nervous system, part III. Amsterdam: North Holland Publishing, 1978:383–394.Google Scholar
  712. 712.
    Peabody JW, Seabury JH. Actinomycosis and nocardiosis. J Chronic Dis 1975;5:374–403.CrossRefGoogle Scholar
  713. 713.
    Gruner OPN. Actinomyces in tonsillar tissue: a histological study of a tonsillectomy material. Acta Pathol Microbiol Scand 1969;76:239–244.PubMedCrossRefGoogle Scholar
  714. 714.
    Coleman RM, Georg LK, Rozzell AR. Actinomyces naeslundii as an agent of human actinomycosis. Appl Microbiol 1969;18:420–426.PubMedGoogle Scholar
  715. 715.
    Dobson SR, Edwards MS. Extensive Actinomyces naeslundii infection in a child. J Clin Microbiol 1987;25:1327–1329.PubMedGoogle Scholar
  716. 716.
    Suzuki JB, Delisle AL. Pulmonary actinomycosis of periodontal origin. J Periodontol 1984;55:581–584.PubMedCrossRefGoogle Scholar
  717. 717.
    Spiegel CA, Telford G. Isolation of Wolinella recta and Actinomyces viscosus from an actinomycotic chest wall mass. J Clin Microbiol 1984;20:1187–1189.PubMedGoogle Scholar
  718. 718.
    Eng RH, Corrado ML, Cleri D, Cherubin C, Goldstein EJ. Infections caused by Actinomyces viscosus. Am J Clin Pathol 1981;75:113–116.PubMedGoogle Scholar
  719. 719.
    Lewis R, Gorbach SL. Actinomyces viscosus in man. Lancet 1972;1:641–642.PubMedCrossRefGoogle Scholar
  720. 720.
    Brown JR, von Lichtenberg F. Experimental actinomycosis in mice. Arch Pathol Lab Med 1970;90:391–402.Google Scholar
  721. 721.
    Brock DW, Georg LK, Brown JM, Hicklin MD. Actinomycosis caused by Arachnia propionica: report of 11 cases. Am J Clin Pathol 1973;59:66–77.PubMedGoogle Scholar
  722. 722.
    Albright L, Toczek S, Brenner VJ, Ommaya AK. Osteomyelitis and epidural abscess caused by Arachnia propionica. Case report. J Neurosurg 1974;40:115–119.PubMedCrossRefGoogle Scholar
  723. 723.
    Klaaborg KE, Kronborg O, Olsen H. Enterocutaneous fistulization due to Actinomyces odontolyticus. Report of a case. Dis Colon Rectum 1985;28:526–527.PubMedCrossRefGoogle Scholar
  724. 724.
    Ruutu P, Pentikainen PJ, Larinkari U, Lempinen M. Hepatic actinomycosis presenting as repeated cholestatic reactions. Scand J Infect Dis 1982;14:235–238.PubMedGoogle Scholar
  725. 725.
    Baron EJ, Angevine JM, Sundstrom W. Actinomycotic pulmonary abscess in an immunosuppressed patient. Am J Clin Pathol 1979;72(4):637–639.PubMedGoogle Scholar
  726. 726.
    Rippon JW, Kathuria SK. Actinomyces meyeri presenting as an asymptomatic lung mass. Mycopathologia 1984;84:187–192.PubMedCrossRefGoogle Scholar
  727. 727.
    Allworth AM, Ghosh HK, Saltos N. A case of Actinomyces meyeri pneumonia in a child. Med J Aust 1986;145:33.PubMedGoogle Scholar
  728. 728.
    Hill GB. Eubacterium nodatum mimics Actinomyces in intrauterine device-associated infections and other settings within the female genital tract. Obstet Gynecol 1992;79:534–538.PubMedGoogle Scholar
  729. 729.
    Jordan HV, Kelly DM, Heeley JD. Enhancement of experimental actinomycosis in mice by Eikenella corrodens. Infect Immun 1984;46:367–371.PubMedGoogle Scholar
  730. 730.
    Kanya KJ. Cervico-facial actinomycosis (case report). J Oral Med 1985;40:166–167.PubMedGoogle Scholar
  731. 731.
    Spinola SM, Bell RA, Henderson FW. Actinomycosis: a cause of pulmonary and mediastinal mass lesions in children. Am J Dis Child 1981;135:336–339.PubMedGoogle Scholar
  732. 732.
    Dicpinigaitis PV, Bleiweiss IJ, Krellenstein DJ, Halton KP, Teirstein AS. Primary endobronchial actinomycosis in association with foreign body aspiration. Chest 1992;101:283–285.PubMedCrossRefGoogle Scholar
  733. 733.
    Golden N, Cohen H, Weissbrot J, Silverman S. Thoracic actinomycosis in childhood. Clin Pediatr (Phila) 1985;24:646–650.CrossRefGoogle Scholar
  734. 734.
    Wright EP, Holmberg K, Houston J. Pulmonary actinomycosis simulating a bronchial neoplasm. J Infect 1983;6:179–181.PubMedCrossRefGoogle Scholar
  735. 735.
    Ariel I, Breuer R, Kamal NS. Endobronchial actinomycosis simulating bronchogenic carcinoma. Diagnosis by bronchial biopsy. Chest 1991;99:493–495.PubMedCrossRefGoogle Scholar
  736. 736.
    Berardi RS. Abdominal actinomycosis. Surg Gynecol Obstet 1979;149:257–266.PubMedGoogle Scholar
  737. 737.
    Weese WC, Smith IM. A study of 57 cases of actinomycosis over a 36-year period—a diagnostic “failure” with good prognosis after treatment. Arch Intern Med 1975;135:1562–1568.PubMedCrossRefGoogle Scholar
  738. 738.
    Frank P, Strickland B. Pulmonary actinomycosis. Br J Radiol 1974;47:373–378.PubMedCrossRefGoogle Scholar
  739. 739.
    Balikian JP, Cheng TH, Costello P, Herman PG. Pulmonary actinomycosis. A report of three cases. Radiology 1978;128:613–616.PubMedGoogle Scholar
  740. 740.
    Webb WR, Sagel SS. Actinomycosis involving the chest wall: CT findings. Am J Radiol 1982;139:1007–1009.Google Scholar
  741. 741.
    Kwong JS, Muller NL, Godwin JD, Aberle D, Grymaloski MR. Thoracic actinomycosis: CT findings in eight patients. Radiology 1992;183:189–192.PubMedGoogle Scholar
  742. 742.
    Hotchi M, Schwarz J. Characterization of actinomycotic granules by architecture and staining methods. Arch Pathol 1972;93:392–400.PubMedGoogle Scholar
  743. 743.
    Oddo D, Gonzalez S. Actinomycosis and nocardiosis: a morphologic study of 17 cases. Pathol Res Pract 1986;181:320–326.PubMedCrossRefGoogle Scholar
  744. 744.
    Harris LF, Kakani PR, Selah CE. Actinomycosis. Surgical aspects. Am Surg 1985;51:262–264.PubMedGoogle Scholar
  745. 745.
    Behbehani MJ, Heeley JD, Jordan HV. Comparative histopathology of lesions produced by Actinomyces israelii, Actinomyces naeslundii, and Actinomyces viscosus in mice. Am J Pathol 1983;110:267–274.PubMedGoogle Scholar
  746. 746.
    Holmberg K, Forsum U. Identification of Actinomyces, Arachnid, Bacterionema, Rothia and Propionibacterium species by defined immunofluorescence. Appl Microbiol 1973;25:834–843.PubMedGoogle Scholar
  747. 747.
    Happonen RP, Viander M. Comparison of fluorescent antibody technique and conventional staining methods in diagnosis of cervicofacial actinomycosis. J Oral Med 1982;11:417–425.CrossRefGoogle Scholar
  748. 748.
    Kleinman PK, Flowers RA. Necrotizing pneumonia after pharyngitis due to Fusobacterium necrophorum. Pediatr Radiol 1984;14:49–51.PubMedCrossRefGoogle Scholar
  749. 749.
    Bartlett JG, Gorbach SL, Thadepalli H, Finegold SM. Bacteriology of empyema. Lancet 1974;1:338–340.PubMedCrossRefGoogle Scholar
  750. 750.
    Morgenstein AA, Citron DM, Orisek B, Finegold SM. Serious infection with Leptotrichia buccalis. Report of a case and review of the literature. Am J Med 1980;69:782–785.PubMedCrossRefGoogle Scholar
  751. 751.
    Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis 1979;119:19–23.PubMedGoogle Scholar
  752. 752.
    Brook I, Martin WJ, Finegold SM. Neonatal pneumonia caused by members of the Bacteroides fragilis group. Clin Pediatr (Phila) 1980;19(8):541–544.CrossRefGoogle Scholar
  753. 753.
    Bayer AS, Nelson SC, Galpin JE, Chow AW, Guze LB. Necrotizing pneumonia and empyema due to Clostridium perfringens. Report of a case and review of the literature. Am J Med 1975;59:851–856.PubMedCrossRefGoogle Scholar
  754. 754.
    File TM Jr, Fass RJ, Perkins RL. Pneumonia and empyema caused by Clostridium sordellii. Am J Med Sci 1977;274:211–212.PubMedCrossRefGoogle Scholar
  755. 755.
    Greenblatt M, Heredia R, Rubenstein L, Alpert S. Bacterial pseudomycosis (“botryomycosis”). Am J Clin Pathol 1964;41:188–193.PubMedGoogle Scholar
  756. 756.
    Winslow DJ. Botryomycosis. Am J Pathol 1959;35:153–167.PubMedGoogle Scholar
  757. 757.
    Martin-Pasqual A, Perez AG. Botryomycosis. Dermatologica 1975;51:302–308.CrossRefGoogle Scholar
  758. 758.
    Hacker P. Botryomycosis. Int J Dermatol 1983;22:455–458.PubMedCrossRefGoogle Scholar
  759. 759.
    Picou K, Batres E, Jarratt M. Botryomycosis. A bacterial cause of mycetoma. Arch Dermatol 1979;115:609–610.PubMedCrossRefGoogle Scholar
  760. 760.
    Winslow DJ, Chamblin SA. Disseminated visceral botryomycosis. Report of a fatal case probably caused by Pseudomonas aeruginosa. Am J Clin Pathol 1960;33:43–47.PubMedGoogle Scholar
  761. 761.
    Leibowitz MR, Asvat MS, Kalla AA, Wing G. Extensive botryomycosis in a patient with diabetes and chronic active hepatitis. Arch Dermatol 1981;117:739–742.PubMedCrossRefGoogle Scholar
  762. 762.
    Washburn RG, Bryan CS, DiSalvo AF, Macher AM, Gallin JI. Visceral botryomycosis caused by Neisseria mucosa in a patient with chronic granulomatous disease. J Infect Dis 1985;151(3):563–564.PubMedCrossRefGoogle Scholar
  763. 763.
    Speir WA, Mitchener JW, Galloway RF. Primary pulmonary botryomycosis. Chest 1971;60:92–93.PubMedCrossRefGoogle Scholar
  764. 764.
    Paz HL, Little BJ, Winkelstein JA. Primary pulmonary botryomycosis. botryomycosis. A manifestation of chronic granulomatous disease. Chest 1992;101:1160–1162.PubMedCrossRefGoogle Scholar
  765. 765.
    Bishop GF, Greer KE, Horwitz DA. Pseudomonas botryomycosis. Arch Dermatol 1976;112:1568–1570.PubMedCrossRefGoogle Scholar
  766. 766.
    Brunken RC, Lichon-Chao N, van den Broeck H. Immunologic abnormalities in botryomycosis. J Am Acad Dermatol 1983;9:428–434.PubMedCrossRefGoogle Scholar
  767. 767.
    Toth IR, Kazal HL. Botryomycosis in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1987;111:246–249.PubMedGoogle Scholar
  768. 768.
    Harman RRM, English MP, Halford M, Saihan EM, Greenham LW. Botryomycosis. A complication of extensive follicular mucinosis. Br J Dermatol 1980;102:215–222.PubMedCrossRefGoogle Scholar
  769. 769.
    Katznelsen D, Vawter GF, Foley GE, Schwachman M. Botryomycosis, a complication in cystic fibrosis. Report of 7 cases. J Pediatr 1964;65:525–539.PubMedCrossRefGoogle Scholar
  770. 770.
    Michaelis L, Gutmann C. Uber Eischluse in Blasentumoren. Z Klin Med 1902;47:208–215.Google Scholar
  771. 771.
    von Hansemann D. Über Malakoplakie der Harnblase. Virchows Arch A Pathol Anat Histopathol 1903;173:302–308.CrossRefGoogle Scholar
  772. 772.
    Damjanov I, Katz SM. Malakoplakia. Pathol Annu 1981;16 (pt 2):103–126.PubMedGoogle Scholar
  773. 773.
    Gupta RK, Schuster RA, Christian WD. Autopsy findings in a unique case of malacoplakia. A cytoimmunohistochemical study of Michaelis-Gutmann bodies. Arch Pathol 1972;93(1):42–48.PubMedGoogle Scholar
  774. 774.
    Colby TV, Hunt S, Pelzmann K, Carrington CB. Malakoplakia of the lung: a report of two cases. Respiration 1980;39(5):295–299.PubMedCrossRefGoogle Scholar
  775. 775.
    Hodder RV, St George-Hyslop P, Chalvardjian A, Bear RA, Thomas P. Pulmonary malakoplakia. Thorax 1984;39(1):70–71.PubMedCrossRefGoogle Scholar
  776. 776.
    Crouch E, White V, Wright J, Churg A. Malakoplakia mimicking carcinoma metastatic to lung. Am J Surg Pathol 1984;8(2):151–156.PubMedCrossRefGoogle Scholar
  777. 777.
    Kwon KY, Colby TV. Rhodococcus equi pneumonia and pulmonary malakoplakia in acquired immunodeficiency syndrome. Pathologic features. Arch Pathol Lab Med 1994;118:744–748.PubMedGoogle Scholar
  778. 778.
    Hamrock D, Azmi FH, O’Donnell E, Gunning WT, Philips ER, Zaher A. Infection by Rhodococcus equi in a patient with AIDS: histological appearance mimicking Whipple’s disease and Mycobacterium avium-intracellulare infection. J Clin Pathol 1999;52(1):68–71.PubMedCrossRefGoogle Scholar
  779. 779.
    Yuoh G, Hove MG, Wen J, Haque AK. Pulmonary malakoplakia in acquired immunodeficiency syndrome: an ultrastructural study of morphogenesis of Michaelis-Gutmann bodies. Mod Pathol 1996;9(5):476–483.PubMedGoogle Scholar
  780. 780.
    Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 1907;18:382–391.Google Scholar
  781. 781.
    Black-Schaffer B. The tinctorial demonstration of a glycoprotein in Whipple’s disease. Proc Soc Exp Biol Med 1949;72:225–227.PubMedGoogle Scholar
  782. 782.
    Yardley JH, Flemming WHI. Whipple’s disease: a note regarding PAS-positive granules in the original case. Bull Johns Hopkins Hosp 1961;109:76–79.PubMedGoogle Scholar
  783. 783.
    Chears WC Jr, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple’s disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology 1961;41:129–138.PubMedGoogle Scholar
  784. 784.
    Yardley JH, Hendrix TR. Combined electron and light microscopy on Whipple’s disease: demonstration of “bacillary bodies” in the intestine. Bull Johns Hopkins Hosp 1961;109:80–98.PubMedGoogle Scholar
  785. 785.
    Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 1992;327(5):293–301.PubMedCrossRefGoogle Scholar
  786. 786.
    Bentley SD, Maiwald M, Murphy LD, et al. Sequencing and analysis of the genome of the Whipple’s disease bacterium Tropheryma whipplei. Lancet 2003;361(9358):637–644.PubMedCrossRefGoogle Scholar
  787. 787.
    Raoult D, Birg ML, La Scola B, et al. Cultivation of the bacillus of Whipple’s disease. N Engl J Med 2000;342(9):620–625.PubMedCrossRefGoogle Scholar
  788. 788.
    Maizel H, Ruffin JM, Dobbins W03. Whipple’s disease: a review of 19 patients from one hospital and a review of the literature since 1950.1970 [classical article][see comments]. Medicine 1993;72(5):343–355.PubMedCrossRefGoogle Scholar
  789. 789.
    Durand DV, Lecomte C, Cathebras P, Rousset H, Godeau P. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine 1997;76(3):170–184.PubMedCrossRefGoogle Scholar
  790. 790.
    Winberg CD, Rose ME, Rappaport H. Whipple’s disease of the lung. Am J Med 1978;65(5):873–880.PubMedCrossRefGoogle Scholar
  791. 791.
    Symmons DP, Shepherd AN, Boardman PL, Bacon PA. Pulmonary manifestations of Whipple’s disease. Q J Med 1985;56(220):497–504.PubMedGoogle Scholar
  792. 792.
    Enzinger FM, Helwig EB. Whipple’s disease. A review of the literature and report of fifteen cases. Virchows Arch A Pathol Anat Histopathol 1963;336:238–269.CrossRefGoogle Scholar
  793. 793.
    Kelly CA, Egan M, Rawlinson J. Whipple’s disease presenting with lung involvement. Thorax 1996;51(3):343–344.PubMedCrossRefGoogle Scholar
  794. 794.
    Pastor BM, Geerken RG. Whipple’s disease presenting as pleuropericarditis. Am J Med 1973;55(6):827–831.PubMedCrossRefGoogle Scholar
  795. 795.
    James TN, Bulkley BH. Whipple bacilli within the tunica media of pulmonary arteries. Chest 1984;86(3):454–458.PubMedCrossRefGoogle Scholar
  796. 796.
    Spain DM, Kliot DA. PAS and Sudan positive pulmonary emboli in Whipple’s disease. Gastroenterology 1962;43:202–205.PubMedGoogle Scholar
  797. 797.
    Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whippleii (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol 2002;118(5):742–748.PubMedCrossRefGoogle Scholar
  798. 798.
    Lepidi H, Costedoat N, Piette JC, Harle JR, Raoult D. Immunohistological detection of Tropheryma whippleii (Whipple bacillus) in lymph nodes. Am J Med 2002;113(4):334–336.PubMedCrossRefGoogle Scholar
  799. 799.
    English CK, Wear DJ, Margileth AM, Lissner CR, Walsh GP. Cat-scratch disease: isolation and culture of the bacterial agent. JAMA 1988;259:1347–1352.PubMedCrossRefGoogle Scholar
  800. 800.
    Slater LN, Welch DF, Hensel D, Coody DW. A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med 1990;323:1587–1593.PubMedCrossRefGoogle Scholar
  801. 801.
    Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 1997;10(2):203–219.PubMedGoogle Scholar
  802. 802.
    Bass JW, Vincent JM, Person DA. The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J 1997;16(2):163–179.PubMedCrossRefGoogle Scholar
  803. 803.
    LeBoit PE, Berger TG, Egbert BM, et al. Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet 1988;1:960–963.PubMedCrossRefGoogle Scholar
  804. 804.
    Maguina C, Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am 2000;14(1):1–22, vii.PubMedCrossRefGoogle Scholar
  805. 805.
    Maurin M, Raoult D. Bartonella (Rochalimaea) quintana infections. Clin Microbiol Rev 1996;9(3):273–292.PubMedGoogle Scholar
  806. 806.
    Agan BK, Dolan MJ. Laboratory diagnosis of Bartonella infections. Clin Lab Med 2002;22(4):937–962.PubMedCrossRefGoogle Scholar
  807. 807.
    Schutze GE. Diagnosis and treatment of Bartonella henselae infections. Pediatr Infect Dis J 2000;19(12):1185–1187.PubMedCrossRefGoogle Scholar
  808. 808.
    Abbasi S, Chesney PJ. Pulmonary manifestations of cat-scratch disease: a case report and review of the literature. Pediatr Infect Dis J 1995;14(6):547–548.PubMedCrossRefGoogle Scholar
  809. 809.
    Foltzer MA, Guiney WB Jr, Wager GC, Alpern HD. Bronchopulmonary bacillary angiomatosis. Chest 1993;104(3):973–975.PubMedCrossRefGoogle Scholar
  810. 810.
    Caniza MA, Granger DL, Wilson KH, et al. Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity. Clin Infect Dis 1995;20(6):1505–1511.PubMedCrossRefGoogle Scholar
  811. 811.
    Marseglia GL, Monafo V, Marone P, Meloni F, Martini A, Burgio GR. Asymptomatic persistent pulmonary infiltrates in an immunocompetent boy with cat-scratch disease. Eur J Pediatr 2001;160(4):260–261.PubMedCrossRefGoogle Scholar
  812. 812.
    Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis 1987;19:491–501.PubMedCrossRefGoogle Scholar
  813. 813.
    Karalus NC, Cursons RT, Leng RA, et al. Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991;46:413–418.PubMedCrossRefGoogle Scholar
  814. 814.
    Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671–674.PubMedCrossRefGoogle Scholar
  815. 815.
    Lim I, Shaw DR, Stanley DP, Lumb R, McLennan G. A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust 1989;151:87–91.PubMedGoogle Scholar
  816. 816.
    Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 1990;69(5):307–316.PubMedCrossRefGoogle Scholar
  817. 817.
    Marrie TJ, Haldane EV, Noble MA, Faulkner RS, Martin RS, Lee SH. Causes of atypical pneumonia: results of a 1-year prospective study. Can Med Assoc J 1981;125:1118–1123.PubMedGoogle Scholar
  818. 818.
    Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 1991;144:312–318.PubMedCrossRefGoogle Scholar
  819. 819.
    Fine MJ, Orloff JJ, Arisumi D, et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med 1990;88:1N–8N.PubMedGoogle Scholar
  820. 820.
    Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995;50(5):543–547.PubMedCrossRefGoogle Scholar
  821. 821.
    Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992;101:1005–1012.PubMedCrossRefGoogle Scholar
  822. 822.
    Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 1990;142:369–373.PubMedCrossRefGoogle Scholar
  823. 823.
    Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523–528.PubMedCrossRefGoogle Scholar
  824. 824.
    Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989;139:877–884.PubMedCrossRefGoogle Scholar
  825. 825.
    Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984;129:668–671.PubMedGoogle Scholar
  826. 826.
    Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991;100:439–444.PubMedCrossRefGoogle Scholar
  827. 827.
    Garibaldi RA, Britt MR, Coleman ML, Reading JC, Pace NL. Risk factors for postoperative pneumonia. Am J Med 1981;70:677–680.PubMedCrossRefGoogle Scholar
  828. 828.
    Corensek MJ, Stewart RW, Keys TF, Mehta AC, McHenry MC, Goormastic M. A multivariate analysis of risk factors for pneumonia following cardiac transplantation. Transplantation 1988;46:860–865.PubMedCrossRefGoogle Scholar
  829. 829.
    Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988;93:318–324.PubMedCrossRefGoogle Scholar
  830. 830.
    England AC, III, Fraser DW. Sporadic and epidemic nosocomial legionellosis in the United States. Epidemiologic features. Am J Med 1981;70:707–711.PubMedCrossRefGoogle Scholar
  831. 831.
    George DL. Epidemiology of nosocomial ventilator-associated pneumonia. Infect Control Hosp Epidemiol 1993;14:163–169.PubMedCrossRefGoogle Scholar
  832. 832.
    Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275(2):134–141.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Washington C. WinnJr.
    • 1
  • P. Rocco LaSala
    • 2
  • Kevin O. Leslie
    • 3
    • 4
  1. 1.Flet